Unspecified acute lower respiratory infection

J10_ACUTELOWERNAS

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 J22
  • Hospital discharge: ICD-8 46699
  • Cause of death: ICD-10 J22
  • Cause of death: ICD-8 46699

2 out of 7 registries used, show all original rules.

6674

4. Check minimum number of events

None

6674

5. Include endpoints

None

6674

6. Filter based on genotype QC (FinnGen only)

6674

Control definitions (FinnGen only)

Control exclude
J10_LOWERINF

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J20-J22
Name in latin
Infectio respiratoria inferior acuta non specificata

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 70784 28053 42315
Only index persons 58725 22829 35896
Unadjusted period prevalence (%)
Whole population 1.03 0.80 1.18
Only index persons 1.16 0.84 1.37
Median age at first event (years)
Whole population 33.27 52.55 20.18
Only index persons 29.85 45.27 20.03

-FinnGen-

Key figures

All Female Male
Number of individuals 6674 2747 3927
Unadjusted period prevalence (%) 1.40 0.94 1.73
Median age at first event (years) 31.61 45.20 22.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5914
Matched controls
59151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.9
323.0
2144
7533
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
+∞
323.0
2735
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
5.0
323.0
1461
3660
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
96.1
323.0
3263
746
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.6
300.2
1668
5844
R03AC02
ATC
salbutamol; inhalant
2.7
287.8
3514
20698
J45.9
ICD-10 Finland
Asthma, unspecified
3.6
269.0
1460
4958
H02AB06
ATC
prednisolone; systemic
2.4
222.7
2999
17604
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.5
222.3
871
2176
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
8.3
199.3
467
607
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.4
198.0
1105
3732
R03BB04
ATC
tiotropium bromide; inhalant
3.9
178.6
828
2388
R03BA05
ATC
fluticasone; inhalant
2.7
156.2
1280
5500
J01MA14
ATC
moxifloxacin; systemic
3.6
150.2
742
2238
R06.0
ICD-10 Finland
Dyspnoea
2.4
150.1
1558
7606
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
148.5
2575
15927
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.7
147.2
710
2098
49300
ICD-8 Finland
Asthma, bronchiale
7.7
143.1
350
482
C03CA01
ATC
furosemide; systemic
2.3
138.9
1713
9043
R03DC03
ATC
montelukast; oral
2.7
130.9
1061
4477
J46
ICD-10 Finland
Status asthmaticus
7.7
129.6
315
429
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
128.6
3051
20924
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.2
123.5
410
839
R03BA02
ATC
budesonide; inhalant
2.5
122.0
1158
5315
J01FA06
ATC
roxithromycin; oral
2.0
121.8
2367
14952
R02
ICPC
Shortness of breath/dyspnoea
2.9
121.8
819
3067
R50.9
ICD-10 Finland
Fever, unspecified
2.6
120.3
999
4255
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
118.7
757
2734
J01MA12
ATC
levofloxacin; systemic
2.4
117.4
1194
5664
J45.1
ICD-10 Finland
Nonallergic asthma
3.8
117.4
542
1531
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.9
116.8
410
891
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
111.5
981
4301
J01AA02
ATC
doxycycline; systemic
1.9
110.5
4397
35376
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
109.7
628
2096
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
108.9
2570
17207
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
105.8
1207
6023
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
103.2
867
3690
R03BA01
ATC
beclometasone; inhalant
2.5
100.9
908
4007
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
95.2
555
1869
J01CA04
ATC
amoxicillin; systemic
1.9
94.2
4588
38206
R96
ICPC
Asthma
3.1
94.0
567
1954
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
93.8
974
4615
R03AC12
ATC
salmeterol; inhalant
4.3
90.2
359
882
J45
ICD-10 Finland
Asthma
2.8
89.9
637
2440
R03AC03
ATC
terbutaline; inhalant
2.4
88.6
879
4058
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.8
87.7
635
2462
R03DA04
ATC
theophylline; systemic, rectal
3.8
87.5
399
1107
48609
ICD-8 Finland
Pneumonia, unspecified
5.7
80.8
243
441
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
4.7
78.5
284
634
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
77.1
1217
6855
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.2
75.2
427
1404
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.8
70.8
246
526
J01DB01
ATC
cefalexin; oral
1.7
70.0
4582
39283
48509
ICD-8 Finland
Bronchopneumonia, unspecified
6.9
70.0
180
266
A02BC02
ATC
pantoprazole; systemic
1.6
69.7
3397
26818
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
+∞
68.9
66
*
R53
ICD-10 Finland
Malaise and fatigue
1.9
68.6
1150
6588
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
66.4
1128
6483
C07AB07
ATC
bisoprolol; oral
1.6
65.2
2365
17154
H02AB07
ATC
prednisone; oral
2.1
64.8
795
4010
J47
ICD-10 Finland
Bronchiectasis
6.8
64.7
169
255
J45.8
ICD-10 Finland
Mixed asthma
4.5
64.5
241
555
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
64.1
690
3278
R05
ICPC
Cough
1.9
63.7
1155
6783
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
11.2
63.3
122
111
I50.0
ICD-10 Finland
Congestive heart failure
2.7
62.4
458
1776
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
61.8
462
1812
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
61.4
321
991
J01FA10
ATC
azithromycin; systemic
1.6
61.1
3060
23953
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.4
60.7
547
2376
N02BE01
ATC
paracetamol; systemic, rectal
1.7
59.8
4661
40700
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
59.3
709
3526
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
59.2
920
5092
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
58.6
563
2524
H02AB04
ATC
methylprednisolone; systemic
2.0
58.5
792
4149
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.5
58.4
295
886
J01FA09
ATC
clarithromycin; systemic
1.7
58.1
1651
11116
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.4
57.3
218
511
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
56.3
966
5533
R06AE07
ATC
cetirizine; oral
1.6
56.2
2239
16445
R81
ICPC
Pneumonia
3.9
55.6
242
643
J01MA02
ATC
ciprofloxacin; systemic
1.6
55.3
2032
14607
A28
ICPC
Limited function/disability NOS
2.0
55.1
783
4176
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.1
54.8
155
261
N02AA05
ATC
oxycodone; systemic
2.0
54.2
769
4098
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
53.5
292
930
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
52.2
1419
9378
AA1AD
NOMESCO Finland
CT of head and brain
1.7
51.4
1207
7642
N05CF01
ATC
zopiclone; oral
1.6
51.0
1633
11271
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
50.9
1398
9256
R03AC13
ATC
formoterol; inhalant
3.1
50.8
300
1010
A03
ICPC
Fever
1.9
50.7
891
5128
A46
ICD-10 Finland
Erysipelas
2.0
50.5
770
4210
SPAT1263
SPAT
Sampling
1.5
50.1
2188
16290
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
50.1
1116
6945
J96.1
ICD-10 Finland
Chronic respiratory failure
5.0
49.6
165
337
N03AX16
ATC
pregabalin; oral
1.7
49.0
1184
7540
N06AX11
ATC
mirtazapine; oral
1.6
48.6
1620
11270
A06AD11
ATC
lactulose; oral
1.9
48.6
759
4181
N02AX02
ATC
tramadol; systemic, rectal
1.5
48.2
2166
16194
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
47.4
1096
6884
J01FF01
ATC
clindamycin; systemic
1.6
47.3
1418
9585
Z3231
NOMESCO Finland
Registered nurse
1.6
47.0
1430
9702
R03AK08
ATC
formoterol and beclometasone; inhalant
3.4
46.6
236
711
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
46.5
746
4146
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
46.0
1057
6615
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
45.6
1406
9557
B01AA03
ATC
warfarin; systemic
1.7
45.5
1001
6182
N05AH04
ATC
quetiapine; oral
1.8
45.3
912
5478
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
65.5
45.2
52
8
J20
ICD-10 Finland
Acute bronchitis
2.2
44.8
493
2347
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
10.9
44.8
87
81
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
44.4
1521
10610
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
44.2
1774
12855
J01DA01
ATC
[U] cefalexin; systemic
1.5
43.9
3310
27443
TGC00
NOMESCO Finland
Bronchial lavation
4.0
43.6
181
462
R06.2
ICD-10 Finland
Wheezing
3.0
43.5
270
940
R05
ICD-10 Finland
Cough
1.8
43.4
920
5608
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
43.2
672
3690
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
42.7
862
5172
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
42.7
2391
18608
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
42.5
1307
8851
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
6.0
42.4
120
203
SPAT1254
SPAT
Administration of medicine
1.8
41.8
785
4599
L28
ICPC
Limited function/disability (L)
1.8
41.7
745
4290
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.1
41.5
169
424
49099
ICD-8 Finland
Bronchitis, unspecified
4.9
41.4
140
292
R01AD09
ATC
mometasone; nasal
1.5
41.3
2243
17303
N05BA01
ATC
diazepam; systemic, rectal
1.9
39.9
689
3916
ZX120
NOMESCO Finland
Intravenous
2.1
39.8
481
2386
R03BB01
ATC
ipratropium bromide; inhalant
3.0
39.7
236
799
R95
ICPC
Chron obstructive pulmonary disease
3.9
39.2
168
441
XG466
NOMESCO Finland
Sleep oxymetry
3.2
39.1
218
706
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
39.0
303
1211
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
38.7
860
5304
N03AX12
ATC
gabapentin; oral
1.8
38.1
765
4567
R42
ICD-10 Finland
Dizziness and giddiness
1.6
38.1
1026
6681
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
38.1
462
2293
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
38.1
631
3535
R05FB02
ATC
cough suppressants and expectorants
1.5
37.5
1794
13405
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.8
37.4
128
271
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.7
37.0
169
469
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
36.7
223
765
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.4
36.7
185
556
R04.2
ICD-10 Finland
Haemoptysis
3.1
36.7
206
671
R11
ICD-10 Finland
Nausea and vomiting
2.1
36.6
422
2049
R4110
NOMESCO Finland
Physiotherapy
1.6
36.4
1302
9102
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
36.3
246
906
M04AA01
ATC
allopurinol; systemic
1.8
36.2
654
3773
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
35.9
1097
7375
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
35.5
1251
8706
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
35.4
360
1650
R29
ICPC
Respiratory symptom/complaint other
2.3
35.4
337
1498
ZXD05
NOMESCO Finland
Urgent procedure
1.5
34.8
1621
12003
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.8
34.7
229
830
N05BA04
ATC
oxazepam; oral
1.6
34.6
1190
8227
N06AB04
ATC
citalopram; systemic
1.6
34.3
1039
6959
A02BC01
ATC
omeprazole; systemic
1.5
34.3
1326
9418
R74
ICPC
Upper respiratory infection acute
1.5
34.3
1381
9902
Z71.8
ICD-10 Finland
Other specified counselling
1.6
34.2
1160
7988
N05AA02
ATC
levomepromazine; systemic
2.6
34.1
262
1038
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
2.5
33.8
270
1092
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
33.8
381
1833
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.8
33.7
233
867
G47.3
ICD-10 Finland
Sleep apnoea
1.6
33.5
1097
7484
R01AD08
ATC
fluticasone; nasal
1.5
33.5
1389
10015
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
33.4
375
1798
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
33.2
202
692
E0000UV
ATC
NA
1.4
32.9
1889
14554
A07AA02
ATC
nystatin; oral
2.3
32.8
315
1406
SPAT1255
SPAT
Intravenous administration of medicine
2.2
32.5
353
1667
N05CD07
ATC
temazepam; oral
1.8
32.3
606
3531
R03BA08
ATC
ciclesonide; inhalant
2.1
32.2
405
2036
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
32.1
768
4820
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
32.1
302
1335
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
32.1
546
3081
N05AX08
ATC
risperidone; systemic
2.0
31.9
439
2290
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
31.9
457
2423
M79.6
ICD-10 Finland
Pain in limb
1.5
31.8
1648
12425
A02BC05
ATC
esomeprazole; systemic
1.4
31.3
1913
14879
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
31.1
388
1947
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
31.0
477
2596
J96.0
ICD-10 Finland
Acute respiratory failure
5.3
31.0
96
183
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.1
30.9
125
313
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.4
30.7
156
473
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.0
30.7
419
2178
A04
ICPC
Weakness/tiredness general
1.7
30.6
631
3786
SPAT1262
SPAT
Handing over of treatment supplies
1.6
30.5
875
5761
207
Kela drug reimbursment
Chronic arrhythmias
1.7
30.3
639
3860
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
30.1
1456
10805
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
107.2
29.7
32
*
R51.80
ICD-10 Finland
Headache
1.7
29.6
703
4395
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
29.3
508
2877
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
29.3
897
6002
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.3
29.3
271
1186
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.0
29.2
420
2230
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
4.0
29.2
119
301
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
29.1
320
1521
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
29.0
1284
9341
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.1
29.0
163
533
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
28.9
621
3770
SPAT1301
SPAT
No procedures
1.4
28.8
1500
11272
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
28.7
408
2153
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
28.7
980
6725
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
28.7
1298
9482
Z2446
NOMESCO Finland
Social worker
2.0
28.6
376
1925
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
28.6
1847
14452
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
28.6
450
2467
L04AA06
ATC
mycophenolic acid; systemic
3.7
28.4
127
348
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.3
28.4
108
256
C03DA01
ATC
spironolactone; oral
1.8
27.9
498
2849
J01FA15
ATC
telithromycin; oral
1.8
27.9
500
2866
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.8
27.9
552
3265
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
27.8
293
1365
R60.0
ICD-10 Finland
Localized oedema
1.8
27.7
489
2788
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
27.7
1136
8120
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
27.7
287
1326
A02BC03
ATC
lansoprazole; oral
1.5
27.7
1343
9942
ZXA05
NOMESCO Finland
Left side
1.5
27.5
1162
8357
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
5.4
27.2
83
156
C01AA05
ATC
digoxin; systemic
1.9
27.2
398
2125
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.8
27.2
116
306
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
7.0
27.0
67
96
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
26.6
595
3653
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
26.6
1184
8602
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.7
26.3
76
134
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
26.3
606
3750
Z3226
NOMESCO Finland
Physiotherapist
1.5
26.1
878
5992
M54.5
ICD-10 Finland
Low back pain
1.4
26.0
1549
11899
J01DA06
ATC
[U] cefuroxime; systemic
1.6
25.9
678
4344
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
25.8
1829
14483
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
25.7
326
1644
J01EA01
ATC
trimethoprim; systemic
1.5
25.6
1035
7362
SPAT1229
SPAT
Assessment of need for aid
2.0
25.4
354
1854
T90
ICPC
Diabetes non-insulin dependent
1.5
25.3
1007
7134
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
11.5
25.3
47
41
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
25.3
466
2691
N30.0
ICD-10 Finland
Acute cystitis
1.7
25.3
569
3496
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
25.2
492
2895
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
25.2
204
834
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
25.2
239
1060
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.0
25.2
146
488
SPAT1325
SPAT
Vaccination
1.4
25.2
1544
11908
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
24.9
1349
10166
A10AE04
ATC
insulin glargine; parenteral
1.8
24.9
479
2806
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
24.8
315
1588
B01AB05
ATC
enoxaparin; parenteral
1.4
24.7
1308
9811
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
251.2
24.7
25
*
N06AA09
ATC
amitriptyline; systemic
1.8
24.5
438
2508
127
Kela drug reimbursment
Transplant complication
3.6
24.4
113
320
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
24.4
801
5432
WYA20
NOMESCO Finland
Home visit
4.0
24.3
99
251
P01AB01
ATC
metronidazole; oral, rectal
1.4
24.3
1750
13860
S97
ICPC
Chronic ulcer skin
2.2
24.0
262
1241
AN1
HP
Coronary angiography
1.7
24.0
518
3142
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.4
23.9
119
357
A02BA02
ATC
ranitidine; systemic
1.5
23.9
883
6149
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
23.9
887
6183
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
23.8
994
7104
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
23.8
660
4290
WX892
NOMESCO Finland
Monitored bed care
1.9
23.8
380
2090
R03AK11
ATC
formoterol and fluticasone; inhalant
3.0
23.8
142
483
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
23.4
1914
15450
N03AG01
ATC
valproic acid; systemic, rectal
2.0
23.3
321
1675
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
23.2
358
1944
N06AX16
ATC
venlafaxine; oral
1.6
23.2
629
4062
SPAT1059
SPAT
Spirometry at the office
2.2
23.0
245
1148
N06AB10
ATC
escitalopram; oral
1.5
23.0
930
6599
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
22.9
258
1240
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
22.6
391
2211
A10BA02
ATC
metformin; oral
1.4
22.6
1244
9378
N06AX21
ATC
duloxetine; oral
1.7
22.5
483
2923
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
22.4
250
1197
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
22.3
2561
21718
46401
ICD-8 Finland
Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)
4.3
22.3
84
199
WX002
NOMESCO Finland
Sedation and analgesia
1.5
22.3
855
5996
E86
ICD-10 Finland
Volume depletion
3.0
22.2
134
460
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
22.1
324
1730
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.8
22.0
73
152
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
22.0
895
6354
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.1
22.0
265
1310
R03DC01
ATC
zafirlukast; oral
4.0
21.9
88
221
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
21.9
192
820
K78
ICPC
Atrial fibrillation/flutter
1.9
21.8
331
1788
ZXA10
NOMESCO Finland
Bilateral
1.5
21.8
816
5689
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
21.6
910
6502
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
21.6
242
1161
R07.3
ICD-10 Finland
Other chest pain
1.8
21.5
415
2433
WX704
NOMESCO Finland
Intubation
1.9
21.4
345
1903
N18.8
ICD-10 Finland
Other chronic renal failure
2.7
21.4
152
578
M10.9
ICD-10 Finland
Gout, unspecified
1.9
21.3
303
1598
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
21.1
1287
9860
N05AD01
ATC
haloperidol; systemic
2.5
21.1
174
720
C09AA05
ATC
ramipril; oral
1.4
21.0
1083
8048
ZXA00
NOMESCO Finland
Right side
1.4
20.9
1200
9096
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.8
20.9
137
498
A01AB09
ATC
miconazole; local oral
1.8
20.8
384
2217
J01FA01
ATC
erythromycin; systemic
1.6
20.7
628
4168
B01AF02
ATC
apixaban; oral
1.8
20.7
399
2337
N05AH02
ATC
clozapine; systemic
2.9
20.7
130
458
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
20.6
493
3078
N05AH03
ATC
olanzapine; systemic
1.9
20.4
310
1677
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
20.4
238
1162
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.5
20.4
163
664
N05CF02
ATC
zolpidem; oral
1.5
20.3
779
5454
WX110
NOMESCO Finland
Local anesthesy
1.3
20.3
3477
30985
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.2
20.3
107
337
L17
ICPC
Foot/toe symptom/complaint
1.4
20.2
1075
8029
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
20.2
306
1651
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
20.2
500
3150
SPAT1216
SPAT
Assessment of functional ability
1.5
20.2
653
4402
49309
ICD-8 Finland
Asthma, Unspecified
11.6
20.2
37
32
B34.9
ICD-10 Finland
Viral infection, unspecified
2.6
20.2
153
607
N03AE01
ATC
clonazepam; systemic
2.0
20.1
277
1444
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
20.1
1651
13265
A01
ICPC
Pain general/multiple sites
1.8
20.0
344
1940
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
20.0
487
3053
R03BC01
ATC
cromoglicic acid; inhalant
3.5
20.0
94
271
ZX108
NOMESCO Finland
Inhalation
5.5
20.0
59
108
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
19.9
481
3013
R01AD01
ATC
beclometasone; nasal
1.5
19.8
706
4861
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
19.8
469
2915
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
19.8
1355
10570
WZC30
NOMESCO Finland
Teaching
1.6
19.8
576
3782
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
19.8
725
5026
J15.8
ICD-10 Finland
Other bacterial pneumonia
5.5
19.7
58
106
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
19.7
408
2441
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
19.7
430
2615
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.9
19.7
82
214
C01DA14
ATC
isosorbide mononitrate; oral
1.5
19.7
664
4517
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
8.1
19.6
44
55
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
19.6
997
7380
R13
ICD-10 Finland
Dysphagia
1.9
19.6
275
1446
EBA00
NOMESCO Finland
Extraction of tooth
1.3
19.4
1552
12404
D07AA02
ATC
hydrocortisone; topical
1.5
19.4
631
4253
R55
ICD-10 Finland
Syncope and collapse
1.6
19.4
473
2964
I50.1
ICD-10 Finland
Left ventricular failure
2.1
19.4
221
1069
C01CA24
ATC
epinephrine; parenteral
1.9
19.3
279
1481
J02AC01
ATC
fluconazole; systemic
1.3
19.3
1603
12889
JN4BD
NOMESCO Finland
Extensive body CT
1.7
19.2
460
2868
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
19.2
147
586
Z94.2
ICD-10 Finland
Lung transplant status
15.6
19.2
31
20
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
19.1
896
6532
N03AX09
ATC
lamotrigine; oral
2.0
19.1
240
1210
E000001
ATC
NA
1.4
19.1
935
6873
A29
ICPC
General symptom/complaint other
1.6
18.9
481
3051
SPAT1260
SPAT
Consultation of another employee
1.5
18.9
769
5447
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.8
18.8
355
2067
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.5
18.8
66
147
M05BA04
ATC
alendronic acid; oral
1.8
18.7
316
1774
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
18.6
388
2326
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.1
18.5
220
1083
Z51.5
ICD-10 Finland
Palliative care
2.0
18.5
252
1310
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
18.4
256
1341
N05AF03
ATC
chlorprothixene; systemic
2.5
18.4
148
606
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
18.4
243
1250
ZXE00
NOMESCO Finland
One hour or less
1.3
18.4
1843
15209
49308
ICD-8 Finland
Asthma, Alia definita
8.7
18.3
39
45
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
18.3
467
2965
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
18.3
711
4986
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.9
18.2
254
1331
H02AB09
ATC
hydrocortisone; systemic
2.8
18.2
121
445
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
18.2
196
927
S06.0
ICD-10 Finland
Concussion
1.6
18.1
482
3095
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.5
18.0
63
140
N04AA02
ATC
biperiden; systemic
2.9
18.0
110
384
WX872
NOMESCO Finland
Intensive care
1.9
17.9
254
1342
GDG10
NOMESCO Finland
Bilateral transplantation of lung
20.1
17.7
26
13
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.4
17.7
150
633
SPAT1097
SPAT
Recording of ECG
1.5
17.7
611
4176
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
17.6
389
2374
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
17.6
212
1049
Z00.0
ICD-10 Finland
General medical examination
1.4
17.5
809
5868
D11
ICPC
Diarrhoea
1.6
17.5
488
3167
A10BH01
ATC
sitagliptin; oral
1.7
17.5
399
2453
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
5.2
17.5
54
105
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.2
17.5
181
840
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
17.5
613
4204
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
10.7
17.4
33
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.0
17.3
232
1198
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
17.3
224
1143
L04AX01
ATC
azathioprine; systemic
2.1
17.3
206
1016
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
17.2
234
1217
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.8
17.1
312
1797
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
17.1
415
2599
S22.3
ICD-10 Finland
Fracture of rib
1.8
17.1
308
1765
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
17.1
317
1837
D07AC01
ATC
betamethasone; topical
1.3
17.1
1521
12311
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
17.1
733
5242
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
17.0
307
1761
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
17.0
517
3428
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.5
17.0
78
222
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
17.0
312
1800
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
50.1
17.0
20
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
16.9
920
6879
N05AC02
ATC
thioridazine; oral
2.9
16.8
103
361
XQ800
NOMESCO Finland
Prick test
1.7
16.7
324
1899
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.9
16.7
244
1302
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
16.7
1054
8083
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.8
16.7
111
407
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
16.7
286
1616
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
16.6
430
2739
I50
ICD-10 Finland
Heart failure
2.4
16.6
143
610
SPAT1240
SPAT
Therapeutic discussion
1.6
16.4
461
2998
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.6
16.4
398
2493
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
16.3
285
1618
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
16.3
185
893
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
16.3
913
6860
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
16.2
1492
12115
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
16.2
530
3575
J05AH02
ATC
oseltamivir; oral
4.9
16.1
52
107
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.2
16.0
84
266
R03BC03
ATC
nedocromil; inhalant
1.8
15.9
283
1615
N05AN01
ATC
lithium; oral
2.5
15.9
129
533
R06AX27
ATC
desloratadine; oral
1.3
15.9
1186
9334
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
15.9
277
1574
SPAT1251
SPAT
Organisation of medication
2.2
15.8
167
782
UJF32
NOMESCO Finland
Coloscopy
1.4
15.7
1059
8200
D07AC13
ATC
mometasone; topical
1.3
15.7
1274
10153
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
5.7
15.6
44
77
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
15.6
1709
14199
Z50.1
ICD-10 Finland
Other physical therapy
1.9
15.6
225
1199
R01AD12
ATC
fluticasone furoate; nasal
1.3
15.5
1303
10432
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
15.5
372
2322
R28
ICPC
Limited function/disability (R)
3.4
15.4
73
214
R06AX13
ATC
loratadine; oral
1.5
15.4
646
4597
A10BH05
ATC
linagliptin; oral
2.0
15.3
202
1040
M05BX04
ATC
denosumab; parenteral
2.1
15.3
178
872
R01
ICPC
Pain respiratory system
3.0
15.2
89
303
XF404
NOMESCO Finland
Ambulatory ECG
1.6
15.2
381
2408
B01AC04
ATC
clopidogrel; oral
1.5
15.2
632
4488
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.1
15.2
83
271
H66.9
ICD-10 Finland
Otitis media, unspecified
1.8
15.1
269
1538
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
3.2
15.1
78
244
N05AA01
ATC
chlorpromazine; systemic, rectal
2.9
15.1
89
305
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.1
15.1
167
800
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
15.1
1232
9820
P03
ICPC
Feeling depressed
1.6
15.1
370
2323
R52.9
ICD-10 Finland
Pain, unspecified
1.7
15.0
337
2067
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
15.0
445
2932
K02.1
ICD-10 Finland
Caries of dentine
1.2
15.0
2798
24765
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
14.9
271
1560
R06AX22
ATC
ebastine; oral
1.4
14.9
724
5295
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
4.6
14.9
51
112
C08CA02
ATC
felodipine; oral
1.6
14.8
382
2430
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
14.8
2295
19865
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.7
14.8
100
372
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
14.8
408
2642
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
31.8
14.8
19
6
J96.9
ICD-10 Finland
Respiratory failure, unspecified
6.0
14.8
40
67
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
14.7
276
1604
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
14.7
1098
8632
WW200
NOMESCO Finland
Immunization
2.2
14.7
144
654
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
14.7
363
2286
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
14.7
133
582
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.7
14.7
99
368
S29
ICPC
Skin symptom/complaint other
1.4
14.6
683
4958
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
14.6
82
273
H03AA01
ATC
levothyroxine sodium; systemic
1.4
14.6
874
6634
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.5
14.5
117
483
J05AB01
ATC
aciclovir; systemic
1.4
14.5
852
6446
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
4.4
14.5
52
120
SPAT1058
SPAT
PEF monitoring instruction
1.7
14.5
328
2017
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
14.4
128
553
J01GB01
ATC
tobramycin; inhalant, parenteral
36.1
14.4
18
5
L04AD01
ATC
ciclosporin; systemic
2.6
14.4
103
398
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.8
14.3
91
328
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
14.3
1105
8722
N06AX03
ATC
mianserin; oral
1.9
14.3
211
1133
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.5
14.3
115
474
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
14.3
212
1141
C10AA01
ATC
simvastatin; oral
1.3
14.3
1780
14999
51900
ICD-8 Finland
Other diseases of respiratory system, Atelectasis pulmonis
22.3
14.2
20
9
A10AE05
ATC
insulin detemir; parenteral
1.7
14.2
269
1569
T78.4
ICD-10 Finland
Allergy, unspecified
2.0
14.2
189
978
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.5
14.2
112
458
GBB00
NOMESCO Finland
Tracheostomy
3.4
14.1
68
203
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
11.9
14.0
25
21
P29
ICPC
Psychological sympt/compl other
1.8
14.0
248
1418
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.0
14.0
183
940
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
14.0
156
751
R78
ICPC
Acute bronchitis/bronchiolitis
2.6
14.0
99
380
K77
ICPC
Heart failure
2.7
13.9
93
346
W19
ICD-10 Finland
Unspecified fall
1.6
13.9
414
2731
TFP20
NOMESCO Finland
Cardiodefibrillation
1.7
13.9
301
1827
J31.0
ICD-10 Finland
Chronic rhinitis
1.7
13.9
322
1991
120
Kela drug reimbursment
Hypogammaglobulinaemia
12.7
13.9
24
19
R4190
NOMESCO Finland
Nutritional therapy
2.1
13.8
162
799
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
13.8
1731
14586
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
13.7
311
1913
S20.2
ICD-10 Finland
Contusion of thorax
1.8
13.7
221
1224
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.7
1821
15445
TK800
NOMESCO Finland
Hemodialysis
2.4
13.6
114
479
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.0
13.6
172
873
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.2
13.6
70
220
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.8
13.6
235
1335
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
13.5
2526
22256
P72
ICPC
Schizophrenia
2.6
13.5
97
376
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
13.5
644
4689
J01DA08
ATC
[U] cefaclor; oral
1.5
13.5
440
2961
J01DC02
ATC
cefuroxime; systemic
1.8
13.5
252
1464
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
1.9
13.4
205
1114
S18
ICPC
Laceration/cut
1.3
13.4
1821
15473
R05CB01
ATC
acetylcysteine; inhalant, oral
3.0
13.4
78
266
F21
ICPC
NA
4.1
13.4
51
125
SPAT1234
SPAT
Support of social functional capacity
1.8
13.4
218
1213
E66.8
ICD-10 Finland
Other obesity
1.8
13.3
220
1229
E66.9
ICD-10 Finland
Obesity, unspecified
2.1
13.3
144
683
WZA90
NOMESCO Finland
Other doctors statement
1.3
13.3
986
7729
R33
ICD-10 Finland
Retention of urine
1.6
13.3
323
2024
A41.8
ICD-10 Finland
Other specified sepsis
2.9
13.3
82
289
XA800
NOMESCO Finland
Neuropsychological investigation
1.9
13.3
190
1010
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.7
13.3
271
1617
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.7
13.2
91
344
B03XA02
ATC
darbepoetin alfa; parenteral
2.7
13.2
91
344
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
13.2
3480
31786
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
13.8
13.2
22
16
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
13.2
253
1482
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
13.2
239
1377
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.4
13.2
112
477
R2110
NOMESCO Finland
Giving the first information
1.7
13.1
269
1608
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
13.1
276
1664
3AC01
NOMESCO Finland
NA
3.5
13.1
60
173
48099
ICD-8 Finland
Viral pneumonia
6.5
13.0
33
51
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.9
13.0
76
260
Z2221
NOMESCO Finland
Medical doctor
1.3
13.0
1216
9855
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
6.0
13.0
35
59
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.1
12.9
142
681
M25.5
ICD-10 Finland
Pain in joint
1.3
12.9
1180
9526
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.9
12.9
181
958
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
12.8
279
1696
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
12.8
799
6092
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.6
12.8
56
155
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.3
12.7
115
505
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
7.2
12.7
30
42
R75
ICPC
Sinusitis acute/chronic
1.9
12.7
175
917
E000003
ATC
NA
1.8
12.7
199
1093
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.3
12.7
111
479
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
12.7
337
2163
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
12.6
321
2038
R03CC03
ATC
terbutaline; systemic
2.6
12.6
94
371
J43.9
ICD-10 Finland
Emphysema, unspecified
3.0
12.6
73
249
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.4
12.6
108
463
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.7
12.5
262
1575
SPAT1283
SPAT
Restricted health certificate
1.4
12.5
785
5994
K59.0
ICD-10 Finland
Constipation
1.8
12.5
218
1242
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
12.5
232
1346
R06AE09
ATC
levocetirizine; oral
1.4
12.5
596
4344
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
12.5
295
1838
R4120
NOMESCO Finland
Occupational therapy
1.7
12.4
265
1603
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.2
12.4
120
542
P01BA02
ATC
hydroxychloroquine; oral
1.6
12.4
306
1927
I95.1
ICD-10 Finland
Orthostatic hypotension
2.1
12.4
145
714
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
13.2
12.4
21
16
N06AB03
ATC
fluoxetine; oral
1.4
12.4
512
3629
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.5
12.4
93
370
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
12.3
391
2615
A04AA01
ATC
ondansetron; systemic, rectal
1.7
12.3
243
1434
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.4
12.3
105
447
ZX112
NOMESCO Finland
Subcutaneous
2.5
12.3
93
373
C08CA01
ATC
amlodipine; oral
1.3
12.3
1464
12223
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
4.2
12.3
45
107
L03
ICPC
Low back symptom/complaint
1.3
12.2
975
7715
N05AB03
ATC
perphenazine; systemic, rectal
1.9
12.2
167
872
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.5
12.2
92
367
WX722
NOMESCO Finland
PEEP
1.8
12.2
204
1143
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.0
12.2
150
754
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.8
12.2
200
1114
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.5
12.2
410
2784
R09
ICPC
Sinus symptom/complaint
1.6
12.2
287
1786
R04.0
ICD-10 Finland
Epistaxis
1.6
12.1
293
1833
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.3
12.1
44
104
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
12.1
268
1642
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.6
12.0
34
61
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
12.0
210
1198
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
12.0
363
2403
WX290
NOMESCO Finland
Other blockade of nerve
1.2
12.0
2109
18392
UGC02
NOMESCO Finland
Rigid bronchoscopy
8.7
12.0
25
29
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.2
12.0
123
575
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
11.9
340
2220
RF210
NOMESCO Finland
NA
2.2
11.9
124
581
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
11.8
535
3857
XG405
NOMESCO Finland
Education on PEF monitoring
2.8
11.8
74
265
R03BB06
ATC
glycopyrronium bromide; inhalant
6.4
11.8
30
47
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
11.8
358
2376
S01.0
ICD-10 Finland
Open wound of scalp
1.6
11.8
344
2261
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.2
11.7
60
189
N05AX12
ATC
aripiprazole; systemic
1.8
11.7
183
1005
I20.09
ICD-10 Finland
Unstable angina
1.7
11.7
229
1353
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
11.6
74
269
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.7
11.6
255
1554
SPAT1252
SPAT
Overall medication plan or its review
1.6
11.6
270
1673
H01
ICPC
Ear pain/earache
1.5
11.6
420
2896
SPAT1060
SPAT
Administration of oxygen
5.5
11.6
33
60
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.8
11.6
73
264
N05BB01
ATC
hydroxyzine; systemic
1.7
11.6
253
1543
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
11.5
629
4687
RF220
NOMESCO Finland
NA
2.7
11.5
76
280
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.1
11.5
133
653
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
11.5
896
7067
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
11.4
205
1179
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
11.4
1716
14688
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.3
11.4
41
96
U04
ICPC
Incontinence urine
1.9
11.4
167
898
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
11.4
121
573
A01AB04
ATC
amphotericin B; local oral
1.8
11.4
182
1005
L16
ICPC
Ankle symptom/complaint
1.5
11.4
399
2731
D01AC02
ATC
miconazole; topical
1.5
11.4
341
2253
K08.3
ICD-10 Finland
Retained dental root
1.6
11.3
298
1909
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
11.3
1788
15382
C08DA01
ATC
verapamil; systemic
1.9
11.3
166
893
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
11.3
557
4079
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
5.3
11.3
33
62
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
11.3
230
1375
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
11.3
325
2129
P76
ICPC
Depressive disorder
1.7
11.3
252
1547
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.4
11.3
53
157
U07
ICPC
Urine symptom/complaint other
1.8
11.2
205
1186
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.5
11.2
86
349
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
11.2
1595
13569
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
11.1
213
1249
ZY010
NOMESCO Finland
Hospital outpatient
1.7
11.1
225
1343
WW500
NOMESCO Finland
Blood transfusion
1.9
11.1
164
884
A05
ICPC
Feeling ill
1.7
11.1
248
1522
L20.0
ICD-10 Finland
Besnier prurigo
1.6
11.0
277
1755
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
11.0
121
583
K04
ICPC
Palpitations/awareness of heart
1.8
11.0
179
1000
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
2.7
11.0
73
272
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
11.0
163
881
M02AA07
ATC
piroxicam; topical
1.2
11.0
1565
13312
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
10.9
422
2949
-1
NOMESCO Finland
NA
1.2
10.9
1540
13079
R10.0
ICD-10 Finland
Acute abdomen
2.0
10.9
136
689
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.2
10.9
55
172
M48.0
ICD-10 Finland
Spinal stenosis
1.5
10.9
437
3079
N03AF01
ATC
carbamazepine; oral, rectal
1.7
10.9
207
1212
S06
ICPC
Rash localized
1.7
10.9
212
1250
S76
ICPC
Skin infection other
1.7
10.8
205
1200
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
10.8
533
3902
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.6
10.8
74
282
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
10.8
260
1627
N05AF05
ATC
zuclopenthixol; systemic
3.0
10.8
59
196
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
10.8
2583
23156
U02
ICPC
Urinary frequency/urgency
1.4
10.7
439
3102
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.7
10.7
226
1366
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
10.7
219
1311
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
10.7
599
4484
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.6
10.6
76
297
A11CC03
ATC
alfacalcidol; systemic
2.2
10.6
105
482
N06AX12
ATC
bupropion; oral
1.6
10.6
274
1746
P01
ICPC
Feeling anxious/nervous/tense
1.5
10.6
395
2741
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
10.6
416
2920
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.3
10.6
52
160
SPAT1057
SPAT
Peak expiratory flow measurement
2.3
10.6
95
419
RD210
NOMESCO Finland
NA
2.3
10.5
91
392
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
10.5
143
749
GX1K5
NOMESCO Finland
Diffusion capacity
10.0
10.5
20
20
SPAT1310
SPAT
Counselling related to known health issue
1.2
10.5
1317
11034
R07.0
ICD-10 Finland
Pain in throat
1.6
10.4
242
1501
R03BB07
ATC
umeclidinium bromide; inhalant
3.7
10.4
44
120
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.4
10.4
87
368
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.8
10.4
66
240
J01XB01
ATC
colistin; inhalant, parenteral
110.2
10.4
11
*
G44.2
ICD-10 Finland
Tension-type headache
1.4
10.4
496
3608
R01AD05
ATC
budesonide; nasal
1.5
10.4
315
2088
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.8
10.4
181
1032
N06AB06
ATC
sertraline; oral
1.4
10.4
444
3168
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
10.4
223
1356
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.4
10.4
84
351
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.5
10.4
47
136
C09CA01
ATC
losartan; oral
1.3
10.4
950
7652
XW000
NOMESCO Finland
Bone marrow biopsy
1.8
10.3
162
893
P28
ICPC
Limited function/disability (P)
3.7
10.3
44
121
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
12.0
10.3
18
15
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.9
10.3
61
213
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.8
10.3
178
1011
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
10.3
217
1311
J37.0
ICD-10 Finland
Chronic laryngitis
2.0
10.3
122
606
N07BB01
ATC
disulfiram; oral
1.7
10.3
224
1367
P06
ICPC
Sleep disturbance
1.5
10.3
385
2675
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
10.3
289
1883
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
5.7
10.2
28
49
RF120
NOMESCO Finland
NA
3.0
10.2
57
192
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
10.2
520
3832
J42
ICD-10 Finland
Unspecified chronic bronchitis
3.2
10.2
52
165
N17
ICPC
Vertigo/dizziness
1.4
10.1
409
2884
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
10.1
269
1727
K92.1
ICD-10 Finland
Melaena
1.7
10.1
202
1203
JN4AD
NOMESCO Finland
Body CT examination
1.6
10.1
286
1867
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
10.1
193
1134
J05AB11
ATC
valaciclovir; oral
1.4
10.1
488
3562
K07
ICPC
Swollen ankles/oedema
1.8
10.1
156
858
J04.0
ICD-10 Finland
Acute laryngitis
2.0
10.1
123
620
UKC02
NOMESCO Finland
Cystoscopy
1.3
10.0
646
4946
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
10.0
165
925
602
Kela drug reimbursment
Children's severe malnutrition
6.4
10.0
25
39
WVA20
NOMESCO Finland
Medicine administration
2.2
10.0
95
428
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
10.0
133
694
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.4
10.0
419
2978
Z08
ICPC
Social welfare problem
2.7
9.9
64
236
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
5.5
9.9
28
51
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.6
9.9
225
1388
N06AB05
ATC
paroxetine; oral
1.6
9.9
246
1553
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
9.9
208
1255
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
4.4
9.9
34
77
205
Kela drug reimbursment
Chronic hypertension
1.3
9.9
1129
9346
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
16.7
9.9
15
9
-69
ICPC
Other reason for encounter NEC
1.8
9.8
154
850
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.0
9.8
119
599
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.1
9.8
112
550
51899
ICD-8 Finland
Bronchiectasis
8.1
9.8
21
26
N07BA03
ATC
varenicline; oral
1.6
9.8
227
1408
SPAT1312
SPAT
General health counselling
1.2
9.8
1343
11350
RS220
NOMESCO Finland
NA
2.5
9.8
73
291
J02AC03
ATC
voriconazole; systemic
7.0
9.8
23
33
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
9.7
405
2875
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.1
9.7
113
556
WX882
NOMESCO Finland
High dependency care
2.0
9.7
122
620
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
9.7
250
1597
XG460
NOMESCO Finland
Short time oxymetry
2.6
9.7
66
252
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
9.6
265
1717
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
9.6
167
954
P99
ICPC
Psychological disorders other
2.0
9.6
113
562
R04
ICPC
Breathing problem other
1.9
9.6
134
711
R99
ICPC
Respiratory disease other
2.4
9.6
76
315
G04CA02
ATC
tamsulosin; oral
1.3
9.6
990
8092
ZX114
NOMESCO Finland
Intramuscular
2.6
9.6
66
254
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.9
9.6
144
785
C07AB02
ATC
metoprolol; systemic
1.3
9.6
809
6443
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
9.5
177
1031
S80.0
ICD-10 Finland
Contusion of knee
1.6
9.5
255
1644
A34
ICPC
General and Unspecified, Blood test
2.7
9.5
62
231
L03AA02
ATC
filgrastim; parenteral
2.1
9.5
107
521
N03AF02
ATC
oxcarbazepine; oral
1.9
9.5
131
691
R25.1
ICD-10 Finland
Tremor, unspecified
2.1
9.5
105
509
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.1
9.5
50
163
D07AB08
ATC
desonide; topical
1.4
9.4
423
3042
A07AA09
ATC
vancomycin; oral
2.7
9.4
60
220
N19
ICD-10 Finland
Unspecified kidney failure
1.9
9.4
132
699
M05BA07
ATC
risedronic acid; oral
2.0
9.4
113
566
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.2
9.4
92
424
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.5
9.4
71
287
R03CC02
ATC
salbutamol; systemic
1.6
9.3
218
1358
R00.2
ICD-10 Finland
Palpitations
1.6
9.3
248
1594
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
9.3
248
1598
J94.8
ICD-10 Finland
Other specified pleural conditions
2.5
9.3
68
271
A99
ICPC
Disease/condition unspecnature/site
1.5
9.3
302
2036
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
9.3
105
513
R21
ICPC
Throat symptom/complaint
1.3
9.2
809
6471
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
9.2
163
937
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
9.2
1379
11757
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
9.1
212
1316
Z94.1
ICD-10 Finland
Heart transplant status
6.7
9.1
22
33
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
9.1
505
3777
T89
ICPC
Diabetes insulin dependent
1.7
9.1
180
1072
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.0
9.1
104
512
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.2
9.1
90
418
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
9.0
229
1457
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.3
9.0
26
49
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
9.0
594
4563
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
7.0
9.0
21
30
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.1
9.0
99
481
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
8.9
1090
9080
6BA02
NOMESCO Finland
NA
6.5
8.9
22
34
I45.9
ICD-10 Finland
Conduction disorder, unspecified
3.1
8.9
46
148
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.3
8.9
77
332
U05
ICPC
Urination problems other
1.7
8.9
162
937
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.4
8.9
69
284
N05BA02
ATC
chlordiazepoxide; systemic
2.0
8.9
109
550
J01CA08
ATC
pivmecillinam; oral
1.2
8.9
1358
11591
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
8.9
130
702
WX720
NOMESCO Finland
Own respiration
1.8
8.8
156
894
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
8.8
115
593
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.7
8.8
58
218
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
8.8
247
1609
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
4.0
8.8
33
82
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.9
8.8
123
652
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.2
8.8
83
377
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
8.8
172
1022
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
8.8
161
937
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
8.8
513
3870
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.9
8.8
127
684
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.5
8.7
29
64
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
5.1
8.7
26
51
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.0
8.7
112
575
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
8.7
65
263
WX730
NOMESCO Finland
Conventional respirator
2.3
8.7
74
320
M03BX02
ATC
tizanidine; oral
1.2
8.7
2929
26871
J86.9
ICD-10 Finland
Pyothorax without fistula
3.1
8.7
46
151
N05BA12
ATC
alprazolam; oral
1.4
8.7
391
2818
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.9
8.7
126
677
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
8.7
339
2376
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.6
8.6
242
1578
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.0
8.6
105
529
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
8.6
147
835
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
8.6
66
268
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
4.5
8.6
29
65
F05.9
ICD-10 Finland
Delirium, unspecified
2.2
8.6
81
366
R31
ICD-10 Finland
Unspecified haematuria
1.4
8.6
386
2781
61
HP
Catheterization and pressure measurement of the left side of the heart
2.3
8.6
73
315
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
8.6
1171
9870
Z72.0
ICD-10 Finland
Tobacco use
2.0
8.6
105
531
A03FA02
ATC
cisapride; oral, rectal
1.5
8.6
279
1880
K10.3
ICD-10 Finland
Alveolitis of jaws
1.7
8.6
180
1088
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
8.6
187
1146
M01AX17
ATC
nimesulide; oral
1.3
8.6
961
7924
SPAT1360
SPAT
Extensive global examination
1.5
8.5
280
1893
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
8.5
371
2655
K92.0
ICD-10 Finland
Haematemesis
2.0
8.5
104
523
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
8.5
113
590
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.7
8.5
183
1116
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
4.8
8.5
27
57
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
8.5
492
3702
R03AC19
ATC
olodaterol; inhalant
4.9
8.5
26
53
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.1
8.5
95
465
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.2
8.5
42
132
R03DX07
ATC
roflumilast; oral
6.4
8.5
21
33
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
8.5
44
143
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.0
8.4
106
543
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
8.4
319
2222
M03BX01
ATC
baclofen; systemic
2.4
8.4
69
293
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
90.2
8.4
9
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
8.4
311
2159
I95.9
ICD-10 Finland
Hypotension, unspecified
2.6
8.4
59
232
R52.2
ICD-10 Finland
Other chronic pain
1.8
8.4
126
690
E000002
ATC
NA
1.4
8.3
457
3409
X58
ICD-10 Finland
Exposure to other specified factors
1.3
8.3
613
4786
R1260
NOMESCO Finland
Evaluation of communicative skills
2.3
8.3
71
307
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.6
8.3
199
1246
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
+∞
8.3
8
*
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
8.3
282
1922
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.9
8.3
48
165
N03AX14
ATC
levetiracetam; systemic
2.0
8.3
103
525
N06AA12
ATC
doxepin; systemic
1.6
8.3
196
1227
WX400
NOMESCO Finland
Inhalation anesthesy
1.7
8.3
174
1053
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
1.9
8.3
125
682
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.9
8.3
121
654
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
2.7
8.3
53
196
J03.0
ICD-10 Finland
Streptococcal tonsillitis
1.9
8.3
121
655
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.7
8.2
163
969
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.7
8.2
160
949
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
8.2
831
6761
S70.0
ICD-10 Finland
Contusion of hip
1.8
8.2
134
749
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
8.2
1790
15786
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.0
8.2
98
492
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
8.2
368
2647
A97
ICPC
No disease
1.3
8.2
577
4471
W06
ICD-10 Finland
Fall involving bed
3.6
8.2
35
98
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
3.7
8.2
34
93
A10BB12
ATC
glimepiride; oral
1.5
8.2
267
1806
R35
ICD-10 Finland
Polyuria
1.5
8.2
240
1585
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
8.2
204
1294
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
2.5
8.2
63
257
XX4BW
NOMESCO Finland
NA
6.5
8.2
20
31
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.7
8.1
174
1058
R07.1
ICD-10 Finland
Chest pain on breathing
2.5
8.1
61
248
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
5.1
8.1
24
47
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.6
8.1
56
216
NF3AA
NOMESCO Finland
Femur X-ray examination
2.2
8.1
78
358
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.0
8.1
97
488
P15
ICPC
Chronic alcohol abuse
1.8
8.1
129
717
J20.8
ICD-10 Finland
Acute bronchitis due to other specified organisms
8.1
8.1
17
21
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
8.1
502
3823
TGB20
NOMESCO Finland
Tracheostomy tube replacement
11.7
8.1
14
12
L50.0
ICD-10 Finland
Allergic urticaria
2.0
8.1
96
480
A02BA04
ATC
nizatidine; systemic
1.5
8.0
293
2029
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
6.8
8.0
19
28
F41.00
ICD-10 Finland
Moderate panic disorder
2.3
8.0
67
288
28009
ICD-8 Finland
Iron deficiency anaemias, Unspecified
4.8
8.0
25
52
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.9
8.0
117
633
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.7
8.0
147
857
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
8.0
272
1853
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
8.0
256
1725
S10
ICPC
Boil/carbuncle
1.6
8.0
207
1327
T82
ICPC
Obesity
1.8
8.0
136
776
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
8.0
139
796
348
Kela drug reimbursment
Roflumilast
5.8
8.0
21
36
L02
ICPC
Back symptom/complaint
1.4
8.0
341
2435
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
7.9
219
1426
A08
ICPC
Swelling
1.7
7.9
141
816
C01BD01
ATC
amiodarone; systemic
1.9
7.9
112
599
SPAT1336
SPAT
Request for examination
1.7
7.9
144
836
UJD02
NOMESCO Finland
Gastroscopy
1.6
7.9
175
1075
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
4.4
7.9
27
62
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.1
7.9
86
416
M01AB05
ATC
diclofenac; systemic, rectal
1.2
7.9
3206
29760
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.9
7.9
104
544
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.9
7.9
24
49
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
4.9
7.9
24
49
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.5
7.9
56
222
C08CA13
ATC
lercanidipine; oral
1.4
7.9
460
3470
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
7.7
7.9
17
22
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
2.8
7.9
47
168
R24
ICPC
Haemoptysis
4.0
7.8
29
72
B37.08
ICD-10 Finland
Other candidal stomatitis
3.5
7.8
34
97
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
7.8
131
744
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
7.8
1117
9451
JAH00
NOMESCO Finland
Laparotomy
1.9
7.8
105
552
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.1
7.8
41
135
284
Kela drug reimbursment
Nintedanib and pirfenidone
4.3
7.8
27
63
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.9
7.8
45
156
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
7.8
315
2229
N01
ICPC
Headache
1.4
7.8
390
2868
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
4.1
7.8
28
68
S21
ICPC
Skin texture symptom/complaint
1.4
7.8
444
3338
81
HP
Angiography of the heart and coronary arteries
1.5
7.7
235
1565
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.3
7.7
67
293
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
2.8
7.7
47
170
Z94.0
ICD-10 Finland
Kidney transplant status
2.5
7.7
57
228
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
7.7
486
3709
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
45.0
7.7
9
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.1
7.7
85
415
R03BB05
ATC
aclidinium bromide; inhalant
6.3
7.7
19
30
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
7.7
759
6161
M54
ICD-10 Finland
Dorsalgia
1.4
7.7
445
3353
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
4.1
7.6
28
69
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.4
7.6
63
268
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.7
7.6
140
817
R51
ICD-10 Finland
Headache
1.6
7.6
190
1204
RS230
NOMESCO Finland
NA
3.7
7.6
31
84
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.1
7.6
79
375
N17.8
ICD-10 Finland
Other acute renal failure
2.6
7.6
51
196
I48.2
ICD-10 Finland
Chronic atrial fibrillation
2.0
7.6
88
436
N06DA02
ATC
donepezil; oral
1.6
7.6
191
1215
46104
ICD-8 Finland
Acute sinusitis, Pansinuitis
6.7
7.6
18
27
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
25.0
7.6
10
*
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
11.8
7.6
13
11
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.1
7.6
39
127
R01AD11
ATC
triamcinolone; nasal
1.4
7.5
334
2402
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.3
7.5
66
291
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
8.8
7.5
15
17
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
7.5
346
2504
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
5.1
7.5
22
43
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.3
7.5
714
5766
S19
ICPC
Skin injury other
1.7
7.5
151
906
B80
ICPC
Iron deficiency anaemia
2.2
7.5
74
345
RS122
NOMESCO Finland
NA
5.7
7.5
20
35
A11
ICPC
Chest pain NOS
1.5
7.5
266
1833
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
7.5
260
1782
B01AB04
ATC
dalteparin; parenteral
1.6
7.5
176
1102
-50
ICPC
Medication/prescr/renewal
1.7
7.5
154
928
D07AD01
ATC
clobetasol; topical
1.3
7.4
561
4394
J33.8
ICD-10 Finland
Other polyp of sinus
2.0
7.4
90
457
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.2
7.4
70
318
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.2
7.4
75
351
F20.5
ICD-10 Finland
Residual schizophrenia
3.7
7.4
30
81
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.8
7.4
45
163
F03
ICD-10 Finland
Unspecified dementia
1.7
7.4
155
938
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.0
7.4
89
448
-38
ICPC
Other laboratory test NEC
3.1
7.4
37
118
-1
ICPC
NA
2.2
7.4
70
319
5AB14
NOMESCO Finland
NA
6.4
7.4
18
28
L84
ICPC
Back syndrome without radiat pain
1.7
7.4
158
963
F34.1
ICD-10 Finland
Dysthymia
1.7
7.4
132
764
Z75.5
ICD-10 Finland
Holiday relief care
3.1
7.4
38
124
R5120
NOMESCO Finland
Preparation of an aid
2.0
7.4
91
464
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
2.8
7.4
45
164
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.5
7.4
24
53
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
4.0
7.3
27
67
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
7.3
93
479
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.7
7.3
134
783
Z09
ICPC
Legal problem
3.6
7.3
31
87
196
Kela drug reimbursment
Paricalcitol and cinacalcet
3.9
7.3
28
72
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
1.9
7.3
107
579
R32
ICD-10 Finland
Unspecified urinary incontinence
2.0
7.3
89
453
J12.8
ICD-10 Finland
Other viral pneumonia
3.0
7.3
40
136
R06AX12
ATC
terfenadine; oral
1.6
7.3
187
1198
M35.1
ICD-10 Finland
Other overlap syndromes
4.7
7.3
23
49
A02BA03
ATC
famotidine; systemic
1.7
7.3
144
861
J20.1
ICD-10 Finland
Acute bronchitis due to Haemophilus influenzae
+∞
7.3
7
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.6
7.3
162
998
WX402
NOMESCO Finland
General anaesthesia
1.3
7.3
667
5362
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.9
7.3
95
497
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
7.2
327
2359
RF420
NOMESCO Finland
NA
2.4
7.2
58
245
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.5
7.2
31
88
R79
ICPC
Chronic bronchitis
6.2
7.2
18
29
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
7.2
72
338
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
7.2
348
2545
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.9
7.2
96
505
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.1
7.2
37
121
WX213
NOMESCO Finland
Lower leg blockade
3.2
7.2
35
110
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.9
7.2
92
478
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
7.2
225
1510
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
7.2
182
1162
R06.5
ICD-10 Finland
Mouth breathing
1.4
7.2
369
2724
-62
ICPC
Administrative procedure
1.8
7.2
106
579
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.8
7.2
108
594
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
7.1
66
299
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
3.6
7.1
30
84
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.1
3062
28446
L05
ICPC
Flank/axilla symptom/complaint
1.6
7.1
194
1259
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.3
7.1
33
100
R06AX26
ATC
fexofenadine; oral
1.5
7.1
248
1704
N05BE01
ATC
buspirone; oral
1.8
7.1
122
697
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.6
7.1
47
180
R03
ICPC
Wheezing
2.7
7.1
46
173
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
2.4
7.1
57
242
UDC00
NOMESCO Finland
Ear microscopy
1.5
7.1
262
1824
B02.9
ICD-10 Finland
Zoster without complication
1.6
7.1
184
1181
Y0499
ICD-8 Finland
Investigation of respiratory system
2.5
7.1
51
205
K08.80
ICD-10 Finland
Toothache NOS
1.4
7.1
301
2149
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.1
7.1
36
117
J32.4
ICD-10 Finland
Chronic pansinusitis
2.3
7.1
59
253
N05AC01
ATC
periciazine; systemic
4.0
7.1
26
65
L04AX05
ATC
pirfenidone; oral
5.6
7.0
19
34
N18.0
ICD-10 Finland
End-stage renal disease
2.4
7.0
54
224
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
3.6
7.0
29
80
79199
ICD-8 Finland
Headache
2.3
7.0
59
254
S22
ICPC
Nail symptom/complaint
1.5
7.0
201
1323
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
7.0
818
6766
C03AA03
ATC
hydrochlorothiazide; oral
1.4
7.0
320
2316
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
10.0
7.0
13
13
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.6
7.0
158
979
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
7.0
84
424
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.5
7.0
53
217
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.6
7.0
161
1001
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.0
3445
32313
K30
ICD-10 Finland
Functional dyspepsia
1.4
7.0
357
2634
A12BA01
ATC
potassium chloride; oral
1.6
6.9
162
1014
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
2.9
6.9
40
139
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.7
6.9
43
159
R63.1
ICD-10 Finland
Polydipsia
5.1
6.9
20
39
C08DB01
ATC
diltiazem; oral
1.5
6.9
192
1255
TQW80
NOMESCO Finland
Local dermatologic skincare
1.9
6.9
100
543
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.6
6.9
46
177
G41.9
ICD-10 Finland
Status epilepticus, unspecified
3.4
6.9
31
92
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
13.8
6.9
11
8
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.9
2696
24848
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.5
6.9
190
1242
4451
FHL
Guitar cutting
1.8
6.9
117
671
J02.0
ICD-10 Finland
Streptococcal pharyngitis
2.1
6.9
69
325
B02AA02
ATC
tranexamic acid; systemic
1.3
6.9
445
3411
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.1
6.8
74
360
R52.0
ICD-10 Finland
Acute pain
1.8
6.8
118
676
N02AA01
ATC
morphine; systemic, rectal
2.5
6.8
49
196
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
6.8
206
1370
R07
ICPC
Sneezing/nasal congestion
1.5
6.8
230
1570
N06AA10
ATC
nortriptyline; systemic
2.0
6.8
76
374
GD1LA
NOMESCO Finland
GD
2.4
6.8
53
222
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
4.4
6.8
23
53
R49.01
ICD-10 Finland
Functional dysphonia
1.8
6.8
101
552
G04BD07
ATC
tolterodine; oral
1.6
6.8
175
1121
W10
ICD-10 Finland
Fall on and from stairs and steps
1.6
6.8
183
1187
U28
ICPC
Limited function/disability (U)
2.8
6.8
40
142
G40
ICD-10 Finland
Epilepsy
2.8
6.8
40
142
P20
ICPC
Memory disturbance
1.3
6.8
403
3050
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.1
6.8
73
353
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.8
6.8
41
149
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.9
6.8
95
510
D01
ICPC
Abdominal pain/cramps general
1.4
6.8
378
2833
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.9
6.8
93
496
C02AC05
ATC
moxonidine; oral
1.6
6.8
160
1004
304
Kela drug reimbursment
Dornase alfa
40.1
6.8
8
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
40.1
6.8
8
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
6.7
290
2078
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
6.7
309
2236
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
6.7
287
2051
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
6.7
291
2085
U71
ICPC
Cystitis/urinary infection other
1.6
6.7
182
1182
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.5
6.7
227
1550
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
2.9
6.7
39
137
L88
ICPC
Rheumatoid/seropositive arthritis
1.7
6.7
124
726
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.7
6.7
117
675
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
4.7
6.7
21
45
M54.2
ICD-10 Finland
Cervicalgia
1.5
6.7
250
1744
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
7.2
6.7
15
21
A12AA04
ATC
calcium carbonate; oral
2.2
6.7
65
301
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.1
6.7
70
335
F20
ICD-10 Finland
Schizophrenia
3.0
6.7
36
122
D12
ICPC
Constipation
1.8
6.7
111
628
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.3
6.7
57
249
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
6.7
271
1921
R09.3
ICD-10 Finland
Abnormal sputum
3.1
6.7
34
111
315
Kela drug reimbursment
Clopidogrel
2.5
6.7
48
193
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
6.7
79
398
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.1
6.7
67
314
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
3.9
6.6
25
64
J01CF02
ATC
cloxacillin; systemic
1.9
6.6
94
507
U01
ICPC
Dysuria/painful urination
1.5
6.6
229
1569
A06AH03
ATC
naloxegol; oral
2.7
6.6
43
161
J01
ICD-10 Finland
Acute sinusitis
1.6
6.6
167
1066
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.2
6.6
63
291
R03AC18
ATC
indacaterol; inhalant
3.1
6.6
33
106
4222
FHL
Endonasal etmoidectomy
3.1
6.6
33
106
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
2.8
6.6
39
139
L14
ICPC
Leg/thigh symptom/complaint
1.4
6.6
259
1823
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
6.6
493
3858
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.1
6.6
67
317
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.7
6.6
123
723
L12
ICPC
Hand/finger symptom/complaint
1.3
6.6
531
4200
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
6.6
338
2499
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
1.9
6.6
83
429
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
6.6
257
1807
318
Kela drug reimbursment
Teriparatide
4.6
6.6
21
46
J30.3
ICD-10 Finland
Other allergic rhinitis
1.7
6.6
133
800
SPAT1285
SPAT
Provision of consultation response
1.5
6.6
188
1240
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
2.7
6.5
40
147
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
6.5
242
1683
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
2.4
6.5
53
226
Z00.8
ICD-10 Finland
Other general examinations
1.4
6.5
269
1914
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
6.5
210
1420
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
6.5
175
1134
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.7
6.5
128
767
R05DB20
ATC
other cough suppressants - combinations
1.5
6.5
204
1372
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.3
6.5
420
3217
RK320
NOMESCO Finland
NA
3.0
6.5
35
119
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
4.1
6.5
23
56
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.7
6.5
134
811
L04AA13
ATC
leflunomide; oral
1.9
6.5
84
438
H26.3
ICD-10 Finland
Drug-induced cataract
3.5
6.5
28
81
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.6
6.5
146
908
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.8
6.5
104
586
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
6.5
173
1123
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.0
6.5
75
374
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.5
6.4
21
47
K84
ICPC
Heart disease other
1.8
6.4
98
542
L29.8
ICD-10 Finland
Other pruritus
2.5
6.4
47
191
R05DA01
ATC
ethylmorphine; oral
1.4
6.4
283
2037
SPAT1281
SPAT
Other administrative function
1.4
6.4
302
2198
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.0
6.4
77
388
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
69.9
6.4
7
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
1.9
6.4
80
413
Z29
ICPC
Social problem NOS
1.9
6.4
82
427
A60
ICPC
General and Unspecified, Result test/procedure
1.6
6.4
150
938
SPAT1101
SPAT
Orthostatic test
1.6
6.4
150
940
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.5
6.4
213
1450
B05XA03
ATC
sodium chloride; parenteral
14.3
6.4
10
7
R60.1
ICD-10 Finland
Generalized oedema
3.4
6.4
28
82
SPAT1272
SPAT
Drug screening
4.0
6.4
23
57
C09DX04
ATC
valsartan and sacubitril; oral
3.0
6.4
34
115
H02AB02
ATC
dexamethasone; systemic
1.4
6.4
324
2392
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
6.4
128
772
L18
ICPC
Muscle pain
1.7
6.3
131
792
X57
ICD-10 Finland
Unspecified privation
1.8
6.3
93
507
F61.0
ICD-10 Finland
Mixed personality disorders
2.0
6.3
72
357
-59
ICPC
Other therap proced/minor surg NEC
1.8
6.3
101
568
NH1AD
NOMESCO Finland
Ankle and foot CT
1.9
6.3
79
408
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.9
6.3
85
450
OAB42
SPAT
NA
1.5
6.3
188
1248
P19
ICPC
Drug abuse
2.5
6.3
45
179
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.7
6.3
41
154
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
4.2
6.3
22
53
68409
ICD-8 Finland
Impetigo, Unspecified
5.9
6.3
16
27
J34.2
ICD-10 Finland
Deviated nasal septum
1.5
6.3
226
1566
104
Kela drug reimbursment
Thyroid insufficiency
1.5
6.3
223
1541
S01AD03
ATC
aciclovir; ophthalmic
1.7
6.3
125
750
NDL22
NOMESCO Finland
Myotomy or tenotomy of wrist or hand, other tendon
+∞
6.2
6
*
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.8
6.2
96
531
M79.1
ICD-10 Finland
Myalgia
1.3
6.2
445
3463
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.9
6.2
36
126
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
6.2
399
3057
GDC00
NOMESCO Finland
Lobectomy of lung
3.3
6.2
28
84
R09.1
ICD-10 Finland
Pleurisy
2.1
6.2
65
314
D10
ICPC
Vomiting
1.5
6.2
218
1504
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
3.2
6.2
30
95
N05AB01
ATC
dixyrazine; systemic
2.2
6.2
57
260
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.1
6.2
22
54
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
6.2
176
1160
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.2
246
1739
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
6.2
168
1094
C05AA08
ATC
fluocortolone; rectal, topical
1.3
6.2
550
4409
N30
ICD-10 Finland
Cystitis
1.5
6.2
226
1572
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.4
6.2
279
2018
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.6
6.2
25
69
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.3
6.1
54
241
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.3
6.1
54
241
RF221
NOMESCO Finland
NA
4.5
6.1
20
45
H05AA02
ATC
teriparatide; parenteral
4.5
6.1
20
45
L04
ICPC
Chest symptom/complaint
1.5
6.1
204
1392
XF640
NOMESCO Finland
NA
1.8
6.1
101
574
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.5
6.1
177
1171
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.1
6.1
30
96
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
7.7
6.1
13
17
E87.6
ICD-10 Finland
Hypokalaemia
1.8
6.1
103
591
G04BD11
ATC
fesoterodine; oral
1.8
6.1
97
545
R05CA10
ATC
expectorants - combinations
1.9
6.1
77
399
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.6
6.1
147
931
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
2.7
6.1
37
136
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.5
6.1
190
1278
M79.7
ICD-10 Finland
Fibromyalgia
1.8
6.1
95
531
E87.5
ICD-10 Finland
Hyperkalaemia
2.1
6.1
64
310
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
4.6
6.1
19
41
ZY000
NOMESCO Finland
Hospital inpatient
2.2
6.1
54
243
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
2.9
6.1
35
122
B01AC07
ATC
dipyridamole; systemic
1.6
6.1
164
1067
P74
ICPC
Anxiety disorder/anxiety state
1.7
6.1
125
758
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
6.1
494
3915
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.3
6.1
50
216
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.2
6.1
58
268
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.5
6.0
43
170
0086X
ICD-9 Finland
Intestinal infections due to other organisms, Enteritis due to specified virus[ENTERITIS VIROSA NUD]
3.1
6.0
30
97
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.5
6.0
198
1344
JDB00
NOMESCO Finland
Gastrostomy
6.7
6.0
14
21
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.5
6.0
43
171
C07AA05
ATC
propranolol; systemic
1.2
6.0
726
6029
L04AA01
ATC
[U] ciclosporin; systemic
2.1
6.0
60
281
S01
ICPC
Pain/tenderness of skin
1.6
6.0
143
904
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
6.0
498
3953
Z03
ICPC
Housing/neighbourhood problem
3.0
6.0
31
103
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.0
6.0
31
103

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
2773
13359
2.84
307.65
6.4
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1539
5266
3.50
307.65
2.7
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1915
7649
3.11
307.65
2.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1534
5212
3.52
307.65
2.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
457
1077
4.48
177.39
2.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
444
1043
4.49
172.98
2.4
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1250
5589
2.52
168.50
10.0
7.7
kpa
5.2
5.1
1.89
1200
5323
(3027801) Oxygen [Partial pressure] in Arterial blood
1249
5588
2.52
168.11
10.0
7.6
kpa
10.7
12.6
43.79
1200
5329
(3003396) Base excess in Arterial blood by calculation
1237
5590
2.49
162.47
10.1
7.6
mmol/l
1.7
1.0
7.14
1033
4297
(3023419) Bacteria identified in Sputum by Culture
292
504
6.01
161.78
4.6
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
834
3165
2.87
154.99
6.9
5.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1133
5024
2.51
154.34
10.4
8.1
%
94.5
95.8
7.16
1086
4834
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
517
1490
3.68
151.71
3.7
2.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
398
956
4.36
150.38
1.7
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
398
956
4.36
150.38
1.7
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
343
745
4.80
146.96
2.0
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3715
26459
1.91
141.02
9.2
6.1
e9/l
0.2
0.2
2.03
3391
23274
(3001604) Monocytes [#/volume] in Blood
3607
25459
1.91
140.61
8.6
5.9
e9/l
0.6
0.6
24.54
3245
22051
(3006315) Basophils [#/volume] in Blood
3613
25563
1.90
139.28
8.7
5.9
e9/l
0.0
0.0
0.51
3249
22148
(3019198) Lymphocytes [#/volume] in Blood
3682
26287
1.89
137.20
8.7
5.9
e9/l
2.0
1.9
0.14
3364
23208
(3002032) Base excess in Venous blood by calculation
1034
4697
2.42
132.10
5.7
4.0
mmol/l
2.4
1.9
4.37
872
3767
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1035
4717
2.41
131.20
5.7
4.0
kpa
6.0
5.8
3.46
995
4575
(44790047)
269
524
5.31
130.70
2.1
1.4
—
—
—
0
0
(44790049)
269
524
5.31
130.70
2.1
1.4
—
—
—
0
0
(44790048)
269
524
5.31
130.70
2.1
1.4
—
—
—
0
0
(44806118)
269
524
5.31
130.70
2.1
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1026
4666
2.42
130.64
11.0
8.4
g/l
122.3
122.6
0.16
987
4497
(3013650) Neutrophils [#/volume] in Blood by Automated count
3954
29270
1.86
127.27
13.8
8.9
e9/l
4.6
4.1
29.48
3585
25534
(3019069) Monocytes/100 leukocytes in Blood
3402
24083
1.84
126.04
9.5
6.3
%
8.6
8.7
0.43
3258
22621
(42870588) Differential panel, method unspecified - Blood
2617
17085
1.87
125.66
8.5
6.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
3305
23227
1.84
125.00
9.0
6.1
%
0.6
0.7
10.40
3163
21738
(3006504) Eosinophils/100 leukocytes in Blood
3383
23962
1.84
124.57
9.1
6.1
%
2.8
2.9
1.70
3230
22384
(3018010) Neutrophils/100 leukocytes in Blood
3430
24470
1.83
122.65
8.9
5.9
%
59.3
57.2
18.47
3277
22982
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3554
25644
1.83
122.27
8.4
6.0
umol/l
10.9
12.0
6.67
3411
24323
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
805
3381
2.57
121.11
2.1
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
3456
24847
1.81
119.13
9.2
6.1
%
25.7
28.0
26.92
3293
23217
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
288
647
4.61
118.18
1.8
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
547
1908
3.03
117.21
2.6
1.9
ug/l
1.5
2.4
1.27
505
1694
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
266
564
4.87
117.10
1.8
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3080
21515
1.80
115.79
10.6
6.0
mmol/l
1.2
1.2
8.33
2904
19581
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
709
2869
2.65
114.83
1.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
312
763
4.24
114.81
2.6
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2120
13292
1.87
112.82
4.2
3.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3322
23846
1.78
112.82
11.5
6.6
mmol/l
1.2
1.2
3.55
2924
20131
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
264
575
4.74
112.50
2.0
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
731
3113
2.51
106.17
10.3
7.1
mmol/l
25.6
24.4
12.03
690
2899
(3013826) Glucose [Moles/volume] in Serum or Plasma
3905
29712
1.76
105.22
8.3
4.7
mmol/l
6.9
6.7
3.71
3737
27734
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
182
301
6.19
105.10
2.1
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
867
4020
2.33
104.12
4.6
2.9
ng/l
239.1
197.8
1.96
769
3611
(3014111) Lactate [Moles/volume] in Serum or Plasma
915
4365
2.27
102.66
9.5
7.3
mmol/l
1.4
1.4
0.31
874
4182
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1618
9611
1.90
99.77
5.6
3.6
ng/l
385.6
626.5
1.04
1260
7347
(3018418) pH of Serum or Plasma
2146
13931
1.80
99.31
5.8
3.9
ph
7.4
7.4
0.20
407
2695
(3000991) Gas panel - Venous blood
883
4217
2.26
98.56
11.0
8.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
257
610
4.34
98.24
2.1
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2834
19971
1.73
98.04
12.1
8.8
inr
1.2
1.3
0.90
843
5748
(3024354) Oxygen [Partial pressure] in Venous blood
831
3887
2.30
97.40
5.2
3.4
kpa
4.7
4.6
0.66
796
3760
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2336
15630
1.76
96.90
3.5
2.6
u/l
55.7
58.0
0.97
2208
14518
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2048
13202
1.80
96.47
4.5
3.0
ng/l
1888.0
1469.4
2.67
1799
11196
(3005322) IgE [Units/volume] in Serum or Plasma
701
3073
2.43
95.17
1.7
1.3
u/ml
448.2
245.2
1.86
654
2862
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2692
18848
1.72
94.25
5.2
3.4
ng/l
41.2
60.4
2.08
1924
12358
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
633
2694
2.49
91.52
12.9
10.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1143
6222
2.01
90.10
10.3
7.2
mmol/l
103.9
104.5
3.77
1105
6076
(3024561) Albumin [Mass/volume] in Serum or Plasma
2945
21336
1.68
89.26
7.2
4.9
g/l
34.4
35.7
27.86
2764
19853
(3004119) Hemoglobin [Mass/volume] in Venous blood
676
3001
2.39
88.99
5.6
3.3
g/l
127.2
130.6
3.31
661
2934
(3042936) Bacteria identified in Isolate by Culture
1262
7139
1.95
88.91
2.7
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
1594
9737
1.84
88.44
3.8
2.7
mosm/kgh2o
545.4
560.4
1.81
1429
8291
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1758
11118
1.79
86.65
2.4
1.8
mg/l
1.1
1.2
0.34
1425
8407
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
199
430
4.74
85.54
4.6
3.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
788
3803
2.22
85.03
3.7
2.5
g/l
9.9
10.6
5.82
737
3467
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1168
6525
1.96
85.00
9.5
6.0
mmol/l
1.1
1.0
3.42
1107
6100
(3031040) Bacteria [#/volume] in Urine by Automated count
4074
32384
1.66
83.90
6.3
4.1
e6/l
1085.1
1546.4
0.28
60
483
(3037692) Legionella sp identified in Specimen by Organism specific culture
107
126
8.61
83.73
1.8
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
897
4581
2.11
83.70
12.1
7.5
mmol/l
10.3
9.6
2.14
857
4381
(3027273) Bicarbonate [Moles/volume] in Venous blood
562
2366
2.50
82.90
5.9
3.3
mmol/l
25.7
25.2
2.28
543
2287
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1346
7974
1.86
81.54
5.7
3.5
mmol/l
0.8
0.8
1.77
1272
7455
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
200
462
4.43
79.11
2.5
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
213
517
4.22
79.01
2.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
208
496
4.30
78.97
2.3
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2411
17019
1.65
77.67
3.9
3.2
u/l
32.4
35.5
1.50
2314
16153
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
321
1039
3.20
77.66
10.2
5.5
iu/ml
354.2
697.4
0.90
68
144
(3007930) Methemoglobin/Hemoglobin.total in Blood
490
2002
2.56
76.83
7.7
5.5
%
0.9
0.9
0.15
457
1880
(3028026) IgM [Mass/volume] in Serum or Plasma
630
2909
2.29
75.25
2.2
1.8
g/l
1.3
1.3
0.28
580
2666
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
525
2243
2.46
74.81
4.5
2.8
%
0.7
0.7
0.16
512
2135
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
488
2023
2.52
74.17
7.7
5.4
%
1.8
1.7
1.50
457
1896
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4647
38758
1.66
74.05
10.9
7.1
u/l
79.9
78.0
2.08
4498
36598
(3002582) Erythrocytes [#/volume] in Urine
2188
15224
1.65
73.67
4.6
3.1
e6/l
56.6
96.7
1.67
1796
11645
(3028192) IgG subclass 2 [Mass/volume] in Serum
199
485
4.20
73.41
1.5
1.4
g/l
2.7
3.0
1.59
149
333
(3047181) Lactate [Moles/volume] in Blood
413
1587
2.71
73.22
8.9
6.3
mmol/l
1.3
1.3
0.12
379
1391
(3027135) IgG subclass 1 [Mass/volume] in Serum
199
486
4.19
73.21
1.5
1.4
g/l
6.7
6.8
0.12
149
334
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
373
1362
2.84
72.90
1.5
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
198
485
4.18
72.55
1.5
1.4
g/l
0.4
0.4
0.65
149
333
(3007853) Bacteria identified in Skin by Aerobe culture
1050
5971
1.90
71.33
2.2
1.7
—
—
—
0
0
(4062490)
196
490
4.09
69.88
1.5
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1217
7299
1.82
69.63
3.4
2.4
g/l
2.3
2.3
1.73
1143
6781
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1150
6783
1.84
69.47
3.5
2.5
%
20.7
23.6
9.68
934
5807
(3000850) Epithelial cells [#/volume] in Urine
1606
10460
1.71
68.75
3.4
2.5
e6/l
5.1
5.2
0.05
1439
9174
(3030467) Casts [#/volume] in Urine by Automated count
1998
13829
1.63
67.40
4.4
3.0
e6/l
0.4
0.4
0.32
1611
10379
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
497
2180
2.38
66.61
6.7
3.7
%
52.4
49.0
2.28
492
2153
(3022948) Iron [Moles/volume] in Serum or Plasma
1274
7888
1.76
64.94
3.4
2.4
umol/l
11.7
13.4
15.13
1198
7347
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
971
5537
1.88
64.92
5.9
4.3
u/l
247.6
241.5
0.60
933
5222
(40758558) Short blood count panel - Blood
1856
12726
1.64
64.46
10.0
6.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
550
2560
2.25
64.11
11.8
10.1
mmol/l
24.6
24.2
1.42
507
2387
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
145
309
4.77
63.38
1.7
1.3
u/ml
1.0
1.0
0.01
91
117
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2097
14886
1.60
62.78
3.0
2.1
u/l
198.9
230.9
0.94
1999
13997
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
539
2510
2.25
62.72
5.0
4.5
mmol/l
24.6
24.0
3.91
488
2274
(3018095) Leukocytes [#/volume] in Urine
2405
17669
1.56
61.84
5.4
3.6
e6/l
96.6
87.7
0.16
1893
12565
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1242
7737
1.74
61.60
3.0
2.3
s
30.1
29.9
0.49
1209
7510
(3024891) Influenza virus A+B Ag [Presence] in Specimen
356
1391
2.65
60.92
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1933
13566
1.60
60.21
4.3
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
280
976
2.95
59.48
2.2
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
306
1121
2.81
59.33
9.8
7.5
mmol/l
11.0
11.3
0.85
276
1010
(3017181) Myelocytes/100 leukocytes in Blood
765
4146
1.95
59.31
5.5
4.1
%
0.8
0.9
0.65
252
1141
(3018572) Chloride [Moles/volume] in Blood
306
1122
2.81
59.23
9.8
7.5
mmol/l
104.5
105.2
1.58
276
1011
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
559
2708
2.16
58.87
2.3
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1258
7954
1.72
58.85
4.0
2.8
e6/l
2.8
2.1
1.92
728
4256
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
156
377
4.21
58.21
2.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
156
377
4.21
58.21
2.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
156
377
4.21
58.21
2.6
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4154
34635
1.53
57.81
5.8
4.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
614
3132
2.06
56.37
12.8
9.6
%
0.6
0.7
1.24
605
3110
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
243
808
3.08
56.07
4.5
3.0
u/ml
2867.8
1406.6
0.23
19
47
(3021589) Normoblasts [#/volume] in Blood
2903
22597
1.50
55.20
13.2
9.3
e9/l
0.0
0.0
0.27
2430
18472
(3009261) Glucose [Presence] in Urine by Test strip
3144
24888
1.50
55.00
4.8
3.4
estimate
0.0
0.0
0.03
570
4395
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
610
3139
2.04
54.61
12.7
9.4
%
1.5
1.4
1.86
601
3117
(3035350) Ketones [Presence] in Urine by Test strip
3112
24633
1.49
54.15
4.7
3.4
estimate
0.0
0.0
1.08
571
4457
(3021601) Nitrite [Presence] in Urine by Test strip
3108
24635
1.49
53.46
6.4
4.6
estimate
0.0
0.0
0.50
593
4568
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
142
341
4.23
53.44
1.2
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1769
12497
1.57
52.12
2.7
2.2
mg/l
3.1
2.9
3.35
1556
10746
(3000494) Fungus identified in Specimen by Culture
965
5845
1.76
52.02
2.1
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
612
3207
2.00
51.99
6.7
3.5
kpa
5.2
5.1
2.20
567
2962
(3009445) Proteinase 3 Ab [Units/volume] in Serum
452
2120
2.21
51.44
1.7
1.6
u/ml
20.7
12.3
0.27
13
62
(3024980) IgG subclass 4 [Mass/volume] in Serum
235
814
2.96
50.47
1.6
1.7
g/l
0.6
0.8
1.58
177
622
(3009343) pH of Capillary blood
601
3166
1.99
50.23
6.8
3.5
ph
7.4
7.4
0.10
70
341
(3002179) Metamyelocytes/100 leukocytes in Blood
684
3786
1.90
49.34
5.4
3.9
%
0.6
0.6
0.36
176
828
(3019150) Specific gravity of Urine by Refractometry
1562
10854
1.57
48.97
5.0
3.7
kg/l
1.0
1.0
0.11
212
1581
(3015235) Bicarbonate [Moles/volume] in Capillary blood
299
1197
2.57
48.61
5.9
2.9
mmol/l
24.9
24.7
0.35
261
1040
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
581
3064
1.98
48.35
6.8
3.5
mmol/l
2.2
1.6
3.50
443
2200
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1276
8476
1.62
48.27
3.6
2.7
e6/l
1.5
1.1
0.57
747
4750
(3015736) pH of Urine
2487
19145
1.48
47.82
4.4
3.2
—
5.8
—
0
20
(3013707) Erythrocyte sedimentation rate by Westergren method
4363
37444
1.48
47.35
5.5
3.8
mm/h
14.5
11.1
33.47
4180
34814
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5768
52677
1.70
46.78
28.2
13.1
mg/l
26.7
24.2
7.64
5141
41398
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
370
1677
2.28
45.67
5.3
3.8
u/ml
0.3
0.3
0.30
239
948
(3011412) CD3 cells [#/volume] in Blood
167
502
3.39
45.52
2.6
2.6
e9/l
1.4
1.1
1.91
100
301
(3036481) Cortisol [Moles/volume] in Serum or Plasma
785
4661
1.78
44.90
2.5
2.2
nmol/l
347.9
368.4
1.97
741
4286
(3018405) Lactate [Moles/volume] in Arterial blood
379
1756
2.23
44.35
6.1
4.0
mmol/l
1.3
1.4
0.87
365
1728
(40760892) CBC W Ordered Manual Differential panel - Blood
1624
11648
1.52
43.25
6.5
4.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
990
6327
1.66
43.19
23.7
24.1
inr
1.4
1.4
0.04
108
913
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
133
356
3.79
43.17
2.6
2.8
e9/l
0.2
0.2
0.61
112
304
(3021440) Promyelocytes/100 leukocytes in Blood
683
3945
1.81
42.76
5.8
4.2
%
0.1
0.1
0.11
220
1050
(3026493) Urate [Moles/volume] in Serum or Plasma
1848
13646
1.49
42.65
3.8
2.5
umol/l
3982.6
4184.8
0.08
1648
11985
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
135
371
3.69
42.19
2.6
2.7
e6/l
667.9
519.9
1.77
113
308
(3002385) Erythrocyte distribution width [Ratio]
4953
44004
1.49
41.82
29.6
15.9
%
14.0
13.6
38.68
4894
43040
(3028626) Oxygen [Partial pressure] in Capillary blood
289
1226
2.42
41.49
5.7
3.5
kpa
8.4
8.5
0.20
265
1132
(4010399)
595
3328
1.86
41.27
1.7
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1765
13012
1.48
40.71
5.7
4.1
%
88.6
89.1
0.37
1718
12697
(3020630) Protein [Mass/volume] in Serum or Plasma
671
3913
1.79
40.60
3.5
2.3
g/l
65.3
66.5
3.89
625
3586
(3042631) Mycobacterium sp identified in Specimen
173
570
3.09
40.58
3.7
2.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
868
5468
1.68
39.79
3.1
2.7
%
1.9
1.7
2.80
790
4841
(3025159) Blasts/100 leukocytes in Blood
643
3733
1.80
39.45
5.9
4.2
%
0.0
0.3
1.24
182
886
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
894
5703
1.66
38.99
3.4
2.9
umol/l
9.7
8.8
0.45
770
4970
(3015377) Calcium [Moles/volume] in Serum or Plasma
2077
15922
1.44
38.70
4.5
3.2
mmol/l
2.3
2.3
4.72
1873
14045
(40757373) Influenza virus identified in Isolate
60
89
6.79
38.53
2.1
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1021
6754
1.60
38.41
1.5
1.3
titre
452.7
502.9
0.45
211
1286
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2736
22061
1.41
38.27
3.5
2.8
ug/l
153.1
132.2
2.82
2573
20574
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2448
19377
1.42
38.00
5.0
3.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
131
379
3.51
37.94
2.0
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
591
3399
1.81
37.34
5.5
4.0
ng/l
106.7
90.5
2.52
528
2974
(3019309) Folate [Moles/volume] in Red Blood Cells
1260
8808
1.53
37.05
1.8
1.8
nmol/l
1195.4
1169.0
0.43
1022
6707
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
187
678
2.81
36.97
7.2
7.0
mg/l
11.1
11.4
0.44
172
634
(46235355) HIV 1 and 2 tests - Meaningful Use set
1400
10044
1.50
36.28
2.1
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
320
1505
2.18
36.03
6.7
4.2
mmol/l
3.9
3.9
0.43
297
1404
(3011397) Hemoglobin [Presence] in Urine by Test strip
1547
11355
1.47
35.68
4.6
3.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
133
405
3.33
35.58
2.0
2.4
%
73.6
72.0
0.54
126
387
(3020891) Body temperature
389
1981
2.02
35.50
8.4
4.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
80
169
4.78
35.44
1.5
1.7
u/ml
2186.5
27640.1
—
8
18
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
130
395
3.34
34.90
2.0
2.4
%
12.0
13.8
0.90
82
201
(3021901) Oxygen saturation in Capillary blood
212
846
2.56
34.70
4.4
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
305
1429
2.19
34.67
1.7
1.6
g/l
0.2
0.2
0.02
290
1358
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4112
35819
1.39
34.63
3.7
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2430
19433
1.39
34.62
2.1
1.9
pmol/l
91.8
95.1
3.30
1433
10534
(3008536) Aspergillus sp Ab [Presence] in Serum
55
84
6.59
34.38
1.9
2.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
89
215
4.18
33.34
1.6
2.5
%
31.8
29.3
0.72
84
205
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
731
4606
1.66
33.13
2.6
2.3
g/l
0.2
0.2
0.48
678
4282
(3006245) CD3-CD19+ cells/100 cells in Blood
90
222
4.10
32.79
1.8
2.6
%
10.8
10.9
0.01
82
207
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
307
1475
2.13
32.73
1.7
1.6
g/l
1.2
1.2
0.91
290
1400
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
741
4701
1.65
32.68
3.1
2.7
u/l
78.5
53.8
0.22
627
4072
(3028433) Virus identified in Specimen by Culture
76
165
4.65
32.60
1.3
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
33
28
11.84
32.50
1.4
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5726
53157
1.54
32.47
29.6
15.0
mmol/l
139.4
139.6
11.70
5659
51787
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
685
4273
1.67
32.24
3.0
2.3
ug/l
8.3
7.9
0.10
609
3742
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2450
19813
1.37
31.85
2.7
2.2
nmol/l
75.5
75.0
0.34
2274
17981
(3023103) Potassium [Moles/volume] in Serum or Plasma
5739
53358
1.54
31.73
29.6
15.1
mmol/l
4.0
4.0
0.24
5657
51882
(3029937) Albumin [Presence] in Urine by Test strip
1713
13072
1.42
31.37
5.3
3.8
estimate
0.0
0.0
2.60
569
4339
(3007164) IgA [Mass/volume] in Serum or Plasma
1343
9815
1.46
31.07
1.8
1.4
g/l
2.5
2.4
0.10
954
6184
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
152
542
2.85
31.04
1.2
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
89
227
3.96
31.00
3.5
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1998
15697
1.39
30.75
3.2
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
644
4001
1.67
30.72
3.2
2.6
e9/l
72.2
69.3
1.13
507
2994
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
408
2219
1.89
30.68
2.0
1.7
g/l
1.6
1.5
1.76
364
1891
(4015189)
54
92
5.91
30.35
3.2
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
192
781
2.50
30.22
1.8
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
88
227
3.92
30.19
3.5
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
88
227
3.92
30.19
3.5
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
88
227
3.92
30.19
3.5
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
74
170
4.39
29.61
3.7
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2827
23570
1.35
29.46
5.4
4.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
73
169
4.36
28.93
3.7
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
73
169
4.36
28.93
3.7
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
32
31
10.37
28.88
1.7
1.4
umol/l
53.4
41.8
0.85
32
31
(3017143) Hepatitis C virus Ab [Presence] in Serum
920
6325
1.53
28.53
1.9
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
304
1545
2.01
27.87
4.0
3.3
g/l
3.8
3.5
1.85
292
1462
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
107
335
3.23
27.45
2.1
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
227
1047
2.21
26.85
2.9
2.1
g/l
129.0
130.4
0.28
163
755
(3022313) Gas panel - Capillary blood
415
2365
1.80
26.85
6.8
3.6
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
1.5
1.4
0.02
18
16
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
1.4
2.1
0.34
24
21
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
0.9
2.4
0.64
17
22
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
3.7
4.8
0.23
15
18
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
5.3
3.7
0.33
18
19
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
2.8
1.2
0.89
22
23
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
2.3
3.0
0.16
18
21
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
2.0
0.8
0.90
18
20
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
31
32
9.73
26.75
1.7
1.5
mg/l
2.4
1.0
0.39
17
21
(3026250) Tacrolimus [Mass/volume] in Blood
89
252
3.57
26.73
38.4
35.9
ug/l
7.9
7.3
1.99
77
235
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
324
1709
1.94
26.70
2.0
1.6
titre
472.9
339.8
0.22
14
65
(3044889) 12 lead EKG panel
4030
35668
1.33
26.63
4.3
3.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
195
847
2.34
26.60
3.2
3.0
nmol/l
0.8
0.8
0.14
159
634
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
330
1754
1.93
26.58
3.1
2.4
ug/l
656.8
587.5
0.13
309
1658
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
90
258
3.52
26.54
2.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
288
1464
2.01
26.39
3.7
3.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
224
1036
2.20
26.32
1.9
1.5
u/ml
107.1
113.2
0.35
49
201
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
238
1129
2.15
26.24
1.9
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
520
3190
1.68
25.90
3.2
2.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
38
53
7.21
25.82
3.2
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
27
24
11.29
25.77
1.4
1.0
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
31
34
9.16
25.59
1.7
1.5
mg/l
1.8
1.2
0.27
20
19
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
236
1128
2.13
25.53
1.9
1.4
u/ml
35.3
17.4
—
6
20
(1616796) Gas panel - Central venous blood
228
1085
2.14
24.95
5.5
3.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
66
159
4.18
24.89
1.7
2.7
e6/l
291.4
204.3
0.58
36
84
(40761511) CBC panel - Blood by Automated count
5844
55080
1.49
24.70
22.8
12.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4272
38321
1.32
24.56
4.2
3.7
pmol/l
14.8
14.7
1.47
4001
35095
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
286
1488
1.96
24.54
2.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
331
1810
1.87
24.45
1.3
1.2
u/ml
1.3
0.8
0.31
40
162
(3010421) pH of Blood
260
1322
2.01
23.83
6.5
3.8
ph
7.4
7.4
0.12
215
1109
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
262
1343
1.99
23.47
1.4
1.4
iu/ml
28.1
12.2
—
5
26
(3037756) Immunofixation for Serum or Plasma
203
946
2.18
23.44
2.0
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
220
1059
2.11
23.39
4.1
3.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
265
1373
1.97
23.02
4.4
3.0
mg/l
35.4
45.6
1.22
223
1115
(3034860) Kappa light chains.free [Mass/volume] in Serum
265
1373
1.97
23.02
4.4
3.0
mg/l
56.0
96.6
0.48
221
1108
(40760888) Immunoglobulin light chains.free panel - Serum
217
1047
2.11
22.93
4.7
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1411
10902
1.37
22.83
1.7
1.5
nmol/l
18.6
19.9
3.06
1290
9497
(3009508) Creatinine [Moles/volume] in Urine
1931
15663
1.33
22.62
3.5
3.3
mmol/l
7.7
8.1
3.13
1694
13342
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1294
9890
1.38
22.33
1.6
1.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
81
243
3.36
22.32
38.1
24.0
ug/l
130.5
119.2
0.71
69
196
(3023183) Ammonium ion [Moles/volume] in Plasma
228
1137
2.04
22.07
3.1
2.9
umol/l
33.1
35.6
0.69
204
969
(3023199) Leukocytes [#/volume] in Pleural fluid
139
565
2.49
22.01
1.4
1.5
e6/l
7133.8
2074.3
0.72
101
407
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
77
226
3.44
21.96
2.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
97
331
2.96
21.57
2.6
2.7
%
40.9
39.7
0.18
47
115
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
256
1342
1.94
21.51
4.5
2.9
ratio
3.0
2.9
0.02
28
109
(3048929) Epstein Barr virus Ab [Presence] in Serum
319
1797
1.81
21.43
1.5
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1719
13799
1.33
21.42
4.2
3.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
206
1001
2.09
21.39
3.8
2.3
%
16.5
16.5
0.03
102
480
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
232
1179
2.00
21.32
1.5
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
108
395
2.76
21.16
3.1
2.6
e6/l
633.2
707.6
0.45
44
146
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
258
1366
1.92
21.05
2.2
2.0
mg/l
11.5
10.9
0.56
250
1276
(3045716) Anion gap in Serum or Plasma
77
235
3.30
20.68
1.8
2.5
mmol/l
8.1
9.5
2.14
57
176
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
75
227
3.33
20.41
2.3
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
146
630
2.35
20.30
1.5
1.5
g/l
31.6
32.6
0.46
132
567
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
219
1113
2.00
20.14
1.5
1.3
u/ml
251.7
262.7
0.25
144
704
(40761535) Cells panel - Urine sediment
590
3961
1.54
20.09
4.9
3.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4059
36602
1.28
20.06
3.8
3.1
u/l
55.4
49.1
3.47
3891
34540
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
120
476
2.55
20.04
2.9
2.7
—
—
—
0
0
(3036489) Thrombin time
336
1961
1.75
20.02
3.3
2.5
s
22.7
21.4
1.32
299
1716
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
300
1696
1.81
19.93
4.3
3.1
%
90.8
91.4
0.17
287
1599
(3025941) Bacteria identified in Stool by Culture
455
2885
1.62
19.83
1.4
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
276
1528
1.84
19.63
3.4
2.8
%
198.3
183.1
2.22
266
1452
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
93
328
2.86
19.53
1.7
1.5
u/l
12.9
12.8
0.03
87
314
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
30
44
6.84
19.50
4.1
3.8
mg/l
1.1
1.6
0.37
19
30
(3001964) Herpes simplex virus Ag [Presence] in Specimen
51
123
4.17
19.27
2.4
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
70
212
3.33
19.06
5.3
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1820
14926
1.30
19.01
4.3
4.0
mg/mmol
13.2
9.5
2.23
1319
9907
(3036782) Glucose [Moles/volume] in Pleural fluid
115
460
2.53
18.89
1.3
1.4
mmol/l
6.1
6.4
0.52
105
423
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
44
96
4.61
18.87
1.7
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
419
2638
1.63
18.78
3.9
2.7
e6/l
0.2
0.3
0.57
409
2565
(3000492) Spirometry study
747
5333
1.45
18.75
1.8
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
48
113
4.27
18.72
1.5
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
212
1094
1.97
18.69
1.6
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
122
506
2.44
18.56
1.4
1.5
e6/l
64214.4
64783.1
0.01
72
300
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5010
46590
1.30
18.45
5.0
4.3
mu/l
2.4
2.2
0.13
4746
42973
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
356
2160
1.68
18.43
2.1
1.9
u/l
37.5
39.0
0.76
322
1924
(3009466) Valproate [Moles/volume] in Serum or Plasma
168
801
2.13
18.38
6.5
5.3
umol/l
388.5
366.7
1.33
156
695
(3045788) Cell count panel - Pleural fluid
112
449
2.52
18.33
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
216
1134
1.93
18.12
6.4
4.0
mmol/l
2.7
2.5
0.48
153
736
(3004809) Band form neutrophils/100 leukocytes in Blood
162
775
2.12
17.59
4.3
3.4
%
1.6
1.6
0.08
123
604
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1047
8008
1.36
17.55
1.9
1.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
40
86
4.67
17.47
1.8
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
302
1782
1.73
17.33
3.1
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
302
1784
1.73
17.26
3.1
2.1
g/l
7.6
7.4
0.93
202
1333
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
283
1645
1.75
17.13
1.5
1.6
iu/ml
1.2
0.7
0.26
68
337
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5879
56112
1.40
17.12
14.1
9.6
u/l
27.8
28.1
0.38
5762
54293
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
301
1782
1.72
17.07
3.1
2.1
g/l
3.7
3.9
0.59
195
1268
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
108
441
2.47
17.03
1.3
1.3
u/l
616.4
360.0
1.04
100
419
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
90
336
2.70
17.03
1.2
1.3
u/l
13.5
14.1
0.13
77
309
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1302
10337
1.32
16.93
1.7
1.7
pmol/l
64947050.8
28176204.5
0.82
1124
8738
(3033705) Calcium.ionized [Moles/volume] in Venous blood
132
591
2.26
16.91
4.1
2.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
62
189
3.30
16.75
5.3
4.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1720
14197
1.28
16.68
3.7
3.3
mg/l
769.9
372.5
2.04
1239
9374
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
80
284
2.84
16.66
1.7
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
258
1475
1.78
16.54
2.0
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4978
46462
1.28
16.50
31.8
16.5
g/l
332.0
333.5
25.03
4950
46054
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
109
454
2.42
16.48
1.4
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
337
2077
1.66
16.45
7.4
3.8
mmol/l
25.1
24.7
1.53
329
1923
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1092
8491
1.34
16.33
3.3
3.0
mmol/l
2.5
2.4
2.38
963
7398
(3003181) Sodium [Moles/volume] in Urine
162
800
2.05
16.20
1.4
1.4
mmol/l
57.7
64.3
1.36
138
637
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
67
220
3.07
16.03
1.4
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
80
291
2.77
15.94
1.7
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
63
201
3.15
15.83
1.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
109
463
2.38
15.80
2.6
2.6
%
33.0
43.0
1.48
15
59
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
210
1144
1.86
15.78
1.5
1.6
e6/l
3644.1
1241.3
0.38
173
946
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
210
1144
1.86
15.78
1.4
1.5
e6/l
28.1
23.0
0.12
169
898
(3035880) pH of Pleural fluid
75
266
2.84
15.67
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
154
756
2.06
15.66
2.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
184
964
1.93
15.58
1.5
1.2
titre
552.0
133.0
—
5
20
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
181
945
1.94
15.48
1.8
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1054
8230
1.33
15.23
1.3
1.3
iu/ml
59.3
30.4
0.58
331
2565
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
277
1659
1.70
15.09
3.1
2.1
g/l
9.8
10.3
1.07
225
1402
(3021879) Hepatitis B virus core Ab [Presence] in Serum
583
4136
1.45
15.03
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1461
11954
1.28
14.92
3.1
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
189
1019
1.88
14.69
1.6
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
61
200
3.07
14.67
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
125
583
2.17
14.55
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
6130
59175
1.44
14.53
35.6
19.2
e9/l
251.6
248.5
2.82
6052
57731
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
252
1489
1.72
14.44
1.4
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
6133
59221
1.44
14.40
35.4
19.1
fl
90.9
90.7
2.53
6092
58415
(3035941) MCH [Entitic mass]
6132
59216
1.44
14.32
35.4
19.1
pg
30.2
30.3
2.64
6090
58412
(3012441) Differential panel - Pleural fluid
109
484
2.27
14.31
1.4
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
114
516
2.23
14.30
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
6133
59230
1.44
14.29
35.5
19.2
e12/l
4.5
4.6
24.54
6039
57627
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
36
85
4.25
14.05
1.5
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
6133
59252
1.43
14.04
35.8
19.3
g/l
134.8
137.6
37.04
6090
58445
(3010813) Leukocytes [#/volume] in Blood
6132
59248
1.43
13.96
35.6
19.2
e9/l
7.3
6.7
38.10
6046
57628
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
252
1504
1.70
13.93
3.0
2.2
g/l
0.9
0.9
0.08
225
1303
(21494890) Protein electrophoresis panel - 24 hour Urine
103
452
2.30
13.91
2.6
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
313
1976
1.61
13.91
3.4
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
274
1675
1.66
13.84
3.2
2.1
g/l
3.3
3.1
1.90
199
1308
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
128
618
2.09
13.66
2.7
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
191
1063
1.82
13.46
2.0
1.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
16
17
9.43
13.43
4.0
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
209
1213
1.75
12.80
5.7
3.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
190
1077
1.79
12.63
2.3
3.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
249
1522
1.66
12.61
4.7
4.5
mg/l
1.6
1.4
2.91
235
1412
(3009871) Measles virus Ab [Titer] in Serum
53
176
3.03
12.52
1.5
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
224
1335
1.70
12.48
2.7
2.1
g/l
0.0
0.0
0.35
207
1226
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
534
3860
1.42
12.39
5.2
3.6
mmol/l
1.2
1.2
2.23
505
3380
(4034850)
264
1646
1.63
12.37
14.6
9.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
975
7757
1.30
12.11
1.3
1.2
u/ml
11.5
11.6
0.00
371
3133
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
216
1289
1.70
11.99
1.3
1.4
mg/l
610.7
517.2
0.34
207
1233
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
197
1146
1.74
11.99
1.3
1.4
mmol/l
4.1
3.8
2.43
187
1077
(3047007) Chlamydophila sp Ab [Presence] in Serum
145
770
1.90
11.89
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
555
4069
1.40
11.87
3.7
2.5
ml/min/173m2
65.4
68.4
0.48
241
1582
(3009542) Hematocrit [Volume Fraction] of Blood
5228
49641
1.25
11.82
26.8
14.0
%
39.6
40.5
8.51
3937
37657
(3026389) Candida sp identified in Specimen by Organism specific culture
127
649
1.98
11.67
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
83
359
2.33
11.66
1.4
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
128
660
1.96
11.47
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
133
697
1.93
11.37
1.1
1.1
g/l
1.6
1.5
0.95
120
630
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
61
231
2.66
11.36
2.2
3.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
230
1424
1.64
11.12
1.2
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
952
7635
1.29
11.06
2.0
1.9
%
1.6
1.5
2.52
844
6825
(4198724)
69
282
2.46
11.01
2.0
2.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
58
219
2.66
10.88
1.9
2.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
411
2905
1.44
10.80
3.4
3.3
pmol/l
4.5
4.5
0.26
369
2576
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
46
154
3.00
10.77
4.4
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
141
768
1.85
10.73
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
149
828
1.82
10.64
1.4
1.2
u/ml
3.8
3.5
0.12
61
280
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5123
48698
1.22
10.58
21.1
12.2
ml/min/173m2
83.6
84.0
0.45
4363
40230
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
273
1784
1.55
10.54
2.8
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
26
60
4.35
10.49
1.4
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
24
52
4.63
10.45
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
54
201
2.70
10.43
2.6
2.8
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
33
92
3.60
10.33
1.2
1.2
mmol/l
1.6
1.7
0.15
20
60
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
146
815
1.81
10.29
1.4
1.2
u/ml
4.0
4.3
0.15
67
377
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
86
401
2.16
10.15
1.2
1.2
titre
95.0
156.2
—
6
13
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
86
401
2.16
10.15
1.2
1.2
titre
60.0
209.3
2.97
15
74
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
643
4950
1.33
10.06
4.6
3.2
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
24
54
4.46
10.00
1.2
1.4
%
58.6
74.8
1.08
19
46
(3011288) Drugs identified in Urine by Screen method
258
1687
1.55
9.95
3.4
3.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
99
492
2.03
9.90
1.5
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
787
6256
1.29
9.74
2.6
2.5
ug/g
156.3
131.7
0.95
643
5016
(3035947) Staphylolysin Ab [Units/volume] in Serum
59
239
2.48
9.64
1.2
1.2
iu/ml
5.3
4.0
—
6
17
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
27
69
3.92
9.56
1.1
1.3
u/l
111.1
542.8
0.49
14
51
(3017704) Immunofixation for Urine
60
246
2.45
9.56
1.9
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
173
1039
1.68
9.47
1.4
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
196
1218
1.63
9.40
2.6
2.1
g/l
0.0
0.0
0.00
180
1128
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
198
1235
1.62
9.35
2.6
2.1
g/l
0.0
0.0
0.00
181
1130
(3016650) Hepatitis A virus Ab [Presence] in Serum
149
863
1.74
9.31
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
216
1380
1.58
9.24
2.6
2.0
g/l
36.2
37.6
2.52
187
1190
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
31
90
3.46
9.17
1.2
1.3
ng/l
119.2
61.8
0.65
21
59
(40768446) Kidney Pathology biopsy report
57
234
2.45
9.08
1.6
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
50
193
2.60
9.05
1.2
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
92
461
2.01
9.03
1.3
1.3
nmol/l
1.5
1.4
0.20
86
410
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
287
1967
1.48
8.90
2.6
2.3
u/l
4468.6
4575.1
0.02
104
698
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
150
883
1.71
8.86
1.1
1.2
—
—
—
0
0
(4306422)
141
816
1.74
8.85
1.3
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
35
113
3.11
8.77
1.2
1.3
%
33.0
23.1
0.73
24
94
(3044242) Glucose [Moles/volume] in Arterial blood
60
257
2.35
8.72
1.8
2.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
42
151
2.79
8.72
1.2
1.4
mmol/l
3.0
3.6
0.62
37
141
(3023511) Choriogonadotropin [Units/volume] in Urine
159
959
1.67
8.60
1.5
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
333
2375
1.42
8.38
5.1
3.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
50
201
2.50
8.36
1.2
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
136
793
1.73
8.34
1.2
1.1
%
115.4
115.0
0.05
127
727
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
140
823
1.72
8.34
1.2
1.2
u/l
42.9
38.8
0.15
125
716
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
48
190
2.54
8.29
3.5
2.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
99
531
1.88
8.02
1.5
1.4
promille
1.4
1.4
0.09
82
407
(3008757) Leukocyte morphology finding [Identifier] in Blood
97
517
1.89
8.01
5.5
4.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
61
275
2.23
7.91
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
115
651
1.78
7.84
1.7
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
26
75
3.48
7.80
1.2
1.3
mmol/l
0.4
1.4
1.34
13
51
(1001926) Buprenorphine [Presence] in Urine by Screen method
282
1980
1.44
7.76
2.1
2.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
212
1406
1.52
7.75
1.3
1.3
titre
64.2
96.7
1.48
26
129
(3000093) Morphology [Interpretation] in Blood Narrative
88
460
1.93
7.72
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1285
11046
1.20
7.71
1.3
1.3
u/ml
1.1
1.8
3.88
338
3004
(3000570) Elastase.pancreatic [Mass/mass] in Stool
209
1386
1.52
7.65
1.4
1.4
ug/g
279.5
270.1
0.28
122
792
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
29
91
3.20
7.64
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
17
36
4.73
7.63
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
208
1380
1.52
7.60
1.2
1.2
titre
344.0
1055.2
—
5
33
(3039162) Centromere protein B Ab [Units/volume] in Serum
104
578
1.81
7.55
1.3
1.3
u/ml
40.5
37.5
—
5
29
(3017315) Amylase [Enzymatic activity/volume] in Urine
60
275
2.19
7.50
1.3
1.2
u/l
183.0
475.9
2.60
54
258
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
200
1321
1.53
7.47
1.5
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
155
965
1.62
7.46
1.3
1.2
u/ml
5.6
4.9
0.05
14
77
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
33
114
2.90
7.41
2.2
2.3
umol/l
14.0
16.3
0.64
33
114
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
45
183
2.47
7.38
1.4
1.5
%
58.0
62.9
0.39
33
148
(3000034) Microalbumin [Mass/volume] in Urine
86
454
1.91
7.35
2.5
3.2
mg/l
40.1
59.4
0.49
60
345
(3000475) Leukocytes [#/volume] in Synovial fluid
180
1168
1.56
7.29
1.7
1.6
e6/l
17451.8
14833.0
0.27
130
843
(3019977) pH of Arterial blood
59
272
2.18
7.28
2.5
2.6
ph
7.4
7.4
0.14
16
85
(3017354) Segmented neutrophils/100 leukocytes in Blood
89
480
1.87
7.14
5.2
3.4
%
60.1
58.0
0.34
54
312
(3051651) Icteric interference index of Serum or Plasma
61
290
2.11
6.99
4.2
3.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
23
66
3.49
6.97
12.3
9.3
mmol/l
5.4
6.2
0.62
23
66
(3040151) Glucose [Moles/volume] in Capillary blood
98
550
1.79
6.93
37.1
5.6
mmol/l
7.3
7.5
0.23
81
453
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
42
171
2.47
6.90
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
574
4582
1.28
6.85
4.0
4.1
ug/l
15.4
28.3
0.77
480
3728
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
25
77
3.26
6.81
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1811
20174
0.86
6.81
2.8
2.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
30
104
2.89
6.72
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
30
104
2.89
6.72
1.4
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
52
236
2.21
6.70
1.3
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
52
236
2.21
6.70
1.3
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
213
1464
1.47
6.61
1.3
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
68
345
1.98
6.56
12.5
11.9
mmol/l
0.6
0.6
0.33
61
312
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
104
604
1.73
6.56
1.3
1.1
%
93.8
96.8
0.49
99
570
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
136
850
1.61
6.50
1.1
1.1
au/ml
7.3
11.6
0.58
12
52
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
132
819
1.62
6.50
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
53
246
2.16
6.48
1.8
1.6
iu/ml
1590883.9
1912533.3
—
7
17
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
211
1454
1.47
6.47
1.3
1.1
—
—
—
0
0
(44813793)
68
347
1.97
6.46
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
213
1471
1.46
6.46
1.3
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
18
6.12
6.42
1.3
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
783
6528
1.23
6.36
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
93
528
1.77
6.36
1.6
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
74
392
1.90
6.32
1.2
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
22
5.46
6.28
1.1
2.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
228
1605
1.44
6.26
1.3
1.3
miu/ml
168.9
212.0
0.97
69
713
(3010726) Horse dander IgE Ab [Units/volume] in Serum
152
986
1.55
6.23
1.1
1.1
u/ml
2.7
2.1
0.19
51
238
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
50
231
2.17
6.20
1.7
2.0
umol/l
236.0
132.4
0.57
21
125
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
137
869
1.59
6.18
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
61
305
2.01
6.16
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
29
104
2.80
6.14
1.4
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
41
175
2.35
6.12
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
173
1160
1.50
6.09
1.2
1.1
u/ml
1.8
1.7
0.04
98
479
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
54
260
2.09
6.04
1.2
1.2
u/l
115.4
84.8
1.33
46
217
(4268621)
98
574
1.72
6.04
2.6
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
87
493
1.77
6.01
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
43
189
2.28
6.01
2.7
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
49
228
2.16
5.98
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
408
3179
1.30
5.90
3.9
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
126
793
1.60
5.90
1.5
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
175
1186
1.49
5.87
1.4
1.3
u/ml
10.7
6.3
0.34
19
121
(3016879) Cocaine [Presence] in Urine
319
2406
1.34
5.81
2.2
2.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
113
2.66
5.81
5.8
6.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
52
251
2.08
5.79
1.2
1.2
u/l
45.1
19.1
1.00
45
206
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
132
844
1.58
5.79
4.3
3.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
321
2426
1.34
5.77
2.5
2.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
616
5069
1.24
5.67
1.9
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
45
207
2.18
5.67
2.3
1.5
—
—
—
0
0
(3013512) EKG study
1518
13535
1.16
5.67
5.0
3.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
336
2564
1.33
5.66
2.1
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
123
778
1.59
5.65
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4901
47166
1.15
5.64
6.3
5.4
mmol/mol
41.0
39.6
15.75
4645
44057
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
38
163
2.34
5.64
3.1
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
38
163
2.34
5.64
3.1
2.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
78
438
1.79
5.59
1.2
1.2
u/l
57.3
64.2
0.29
59
291
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
31
122
2.55
5.52
2.6
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
11
21
5.25
5.52
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
337
2587
1.32
5.46
2.1
2.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
67
362
1.86
5.44
1.3
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
44
205
2.15
5.39
2.1
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
44
205
2.15
5.39
2.1
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
14
34
4.12
5.35
2.4
3.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
94
564
1.68
5.35
1.6
1.6
%
62.4
60.0
0.23
70
354
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
66
357
1.86
5.35
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
66
357
1.86
5.35
1.3
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
44
206
2.14
5.33
7.1
6.3
mmol/l
25.6
24.7
0.85
38
195
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
288
3778
0.75
5.28
1.4
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
162
2.29
5.26
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
37
162
2.29
5.26
1.1
1.1
%
93.1
86.5
0.61
24
82
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
174
1208
1.45
5.21
1.4
1.3
u/ml
12.2
8.6
0.28
32
200
(3022493) Free Hemoglobin [Mass/volume] in Plasma
48
235
2.05
5.19
13.8
7.1
mg/l
79.0
1982.8
0.82
40
170
(3027008) Opiates [Presence] in Urine
334
2581
1.31
5.17
2.1
2.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
71
398
1.79
5.15
2.4
2.0
g/24h
1.1
1.8
—
5
30
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
66
362
1.83
5.14
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
66
362
1.83
5.14
1.3
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
462
5686
0.80
5.10
1.7
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
292
1.93
5.09
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
197
1408
1.41
5.05
1.1
1.1
u/ml
3.8
6.6
0.68
11
204
(40759836) Histone Ab [Presence] in Serum by Immunoblot
65
357
1.83
5.04
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
286
1.93
5.04
1.1
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
57
301
1.90
4.99
1.1
1.1
iu/ml
10.2
9.2
0.13
12
76
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
25
93
2.69
4.99
1.6
1.2
mg/l
119.3
123.3
0.01
16
67
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
162
1122
1.45
4.93
1.2
1.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
54
282
1.92
4.90
2.6
2.3
umol/l
16.3
46.7
—
7
29
(3027944) Amphetamines [Presence] in Urine
327
2541
1.30
4.88
2.1
2.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
31
130
2.39
4.87
1.4
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
467
5706
0.80
4.83
4.1
4.1
%
30.4
31.6
1.73
338
3990
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
183
1302
1.42
4.83
1.4
1.2
u/ml
48.5
38.3
0.13
11
75
(3036603) Volume of Urine
57
305
1.88
4.81
2.0
1.5
ml
1567.1
1976.5
1.09
17
67
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
39
182
2.15
4.79
2.5
2.8
umol/l
25.2
28.3
0.79
31
131
(3040893) Potassium [Moles/volume] in Capillary blood
9
10
9.01
4.78
3.7
1.9
mmol/l
4.3
4.6
—
9
10
(3016018) Differential panel - Cerebral spinal fluid
89
544
1.64
4.76
1.4
1.6
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
33
144
2.30
4.76
1.3
1.6
%
1.9
2.8
0.48
23
120
(3034426) Prothrombin time (PT)
42
204
2.07
4.67
1.4
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
35
158
2.22
4.67
1.1
1.2
%
92.6
86.1
0.44
22
80
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
64
359
1.79
4.67
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
232
1729
1.35
4.65
1.3
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
46
232
1.99
4.63
1.6
1.9
%
162.7
148.8
0.51
39
222
(3025018) Bordetella pertussis Ab [Titer] in Serum
52
275
1.90
4.57
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
19
64
2.97
4.54
1.7
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
49
255
1.93
4.52
1.4
1.3
%
43.2
66.3
—
6
28
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
141
970
1.46
4.49
1.4
1.2
u/ml
46.1
36.7
0.26
18
89
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
82
501
1.64
4.43
1.4
1.3
—
24.5
—
0
6
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5116
49630
1.13
4.36
4.5
4.2
mmol/l
6.1
5.9
9.44
4819
45692
(40768800) Prostate Pathology biopsy report
72
1178
0.61
4.35
1.2
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
11
26
4.24
4.35
1.2
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
53
288
1.85
4.31
1.5
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
82
505
1.63
4.30
1.2
1.5
mosm/kgh2o
278.9
280.8
0.33
69
389
(3003327) Ova and parasites identified in Stool by Light microscopy
225
1692
1.34
4.28
1.8
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
158
1122
1.42
4.26
1.9
1.9
iu/l
5.9
4.6
0.47
52
408
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
219
1643
1.34
4.23
3.5
3.5
u/ml
791.4
3716.6
0.98
191
1420
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
16
51
3.14
4.20
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
29
127
2.29
4.18
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
477
3951
1.22
4.18
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
153
1085
1.42
4.17
2.9
2.3
nmol/l
0.9
0.8
1.20
139
913
(3003888) Timothy IgE Ab [Units/volume] in Serum
150
1061
1.42
4.15
1.1
1.1
u/ml
5.0
6.5
0.60
96
566
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
90
574
1.58
4.11
1.9
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
90
574
1.58
4.11
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
73
442
1.66
4.11
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
271
2112
1.30
4.02
2.3
1.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
11
28
3.93
3.97
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
636
5441
1.19
3.96
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
18
64
2.82
3.95
1.6
1.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
112
758
1.49
3.92
1.1
1.0
u/ml
5.2
4.8
0.10
67
300
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
26
112
2.33
3.91
1.2
1.2
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
17
59
2.89
3.89
1.5
1.4
%
19.3
26.8
0.44
11
41
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
32
151
2.12
3.89
2.5
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
341
2748
1.25
3.87
2.1
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
106
713
1.49
3.83
1.1
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
29
3.80
3.80
7.3
3.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
54
309
1.75
3.76
1.9
1.4
u/l
5.6
6.4
0.49
49
265
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
23
96
2.40
3.71
2.4
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
143
1025
1.40
3.71
1.1
1.1
u/ml
0.9
1.4
0.57
76
453
(3035320) C reactive protein [Mass/volume] in Body fluid
58
341
1.71
3.68
2.9
2.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
42
224
1.88
3.67
2.2
2.4
nmol/l
154.7
149.3
0.11
36
195
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
36
183
1.97
3.62
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
52
300
1.74
3.54
1.3
1.1
ratio
1.0
1.0
0.09
21
97
(3032352) Blasts [#/volume] in Cerebral spinal fluid
16
57
2.81
3.51
1.9
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
86
565
1.53
3.50
1.9
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
31
151
2.06
3.50
8.5
6.6
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
8
13
6.16
3.50
1.3
1.0
mg/l
67.2
59.2
—
8
13
(21494755) Public health laboratory ask at order entry panel
563
6546
0.85
3.49
1.3
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
77
494
1.57
3.49
4.1
3.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
117
820
1.43
3.47
1.1
1.1
u/ml
7.4
3.4
1.47
64
326
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
65
401
1.63
3.46
2.4
2.0
u/field
1.4
1.8
0.45
30
168
(3037121) Protein [Mass/volume] in Urine
230
1793
1.29
3.46
4.4
3.4
g/l
0.3
0.3
0.11
130
822
(3024522) Salmonella sp identified in Specimen by Organism specific culture
86
568
1.52
3.43
1.9
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
680
5923
1.16
3.42
1.4
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
16
58
2.76
3.41
4.0
9.4
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
22
94
2.34
3.40
2.5
2.4
mmol/l
3.0
2.4
0.49
22
84
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
415
3471
1.21
3.35
2.2
2.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
10
27
3.71
3.35
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
42
232
1.82
3.32
1.2
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
69
441
1.57
3.21
1.8
1.5
%
26.9
27.2
0.02
47
271
(3044007) Cell count panel - Peritoneal fluid
29
143
2.03
3.20
2.1
2.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
28
3.58
3.19
5.5
6.5
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
8
15
5.34
3.19
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
84
562
1.50
3.18
1.9
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
84
563
1.50
3.16
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
84
564
1.50
3.13
1.9
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
69
444
1.56
3.12
1.6
1.3
e6/l
14876.5
107976.4
2.28
45
305
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
44
252
1.75
3.11
2.3
2.4
umol/l
59.6
52.8
0.49
34
215
(3021788) Differential panel - Synovial fluid
124
898
1.39
3.10
1.6
1.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
23
105
2.19
3.08
1.4
1.1
%
85.6
78.9
—
10
35
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
44
253
1.74
3.07
1.7
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
322
2651
1.23
3.07
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
150
1123
1.34
3.05
1.5
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
111
791
1.41
3.05
1.7
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
39
217
1.80
3.04
3.6
3.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
31
160
1.94
3.03
2.0
2.0
e6/l
4601.9
15636.7
0.48
15
92
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
246
1972
1.26
3.00
1.1
1.1
u/ml
3.3
1.2
—
5
24
(3023487) Leukocytes [#/volume] in Peritoneal fluid
34
183
1.86
2.95
2.0
2.2
e6/l
429.4
776.8
1.19
25
137
(3017732) Neutrophils [#/volume] in Blood
420
3563
1.19
2.94
3.6
2.8
e9/l
4.6
4.2
2.84
342
2858
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
17
4.71
2.91
3.9
5.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
45
265
1.70
2.91
1.6
1.5
u/l
5.9
5.0
0.11
25
131
(3013139) Helicobacter pylori Ag [Presence] in Stool
364
3056
1.20
2.87
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
124
2.02
2.75
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
27
138
1.96
2.74
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
27
139
1.95
2.69
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
50
310
1.62
2.69
1.3
1.3
mmol/l
34.3
35.4
0.11
44
273
(3011985) Renin [Units/volume] in Plasma
91
645
1.42
2.63
1.5
1.5
mu/l
77.8
61.5
0.30
78
572
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
39
228
1.71
2.62
1.1
1.1
%
91.0
96.3
0.52
31
183
(3014051) Protein [Presence] in Urine by Test strip
138
1047
1.32
2.62
2.8
2.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
379
3224
1.19
2.61
1.3
1.2
iu/ml
126.1
147.7
0.53
151
1187
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
54
344
1.57
2.61
1.8
1.9
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
59
384
1.54
2.60
3.4
1.9
mmol/l
8.0
6.7
1.19
52
255
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
372
3164
1.19
2.57
1.3
1.3
au/ml
22.9
52.6
4.63
15
136
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
265
2183
1.22
2.57
2.4
1.8
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
22
107
2.06
2.56
1.5
1.2
%
83.9
72.0
—
9
36
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
405
3475
1.18
2.53
2.4
2.3
au/ml
15.7
22.7
1.17
24
223
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
735
6584
1.13
2.52
2.3
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
669
5969
1.13
2.44
2.2
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1379
12815
1.10
2.38
1.7
1.6
mmol/l
1.6
1.4
5.45
1224
10962
(3042517) Benzodiazepines panel - Urine
14
58
2.42
2.36
1.8
2.8
—
—
—
0
0
(4035726)
463
4043
1.16
2.33
1.5
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
47
299
1.58
2.32
1.8
2.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
59
2.38
2.29
1.1
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
57
381
1.50
2.27
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
54
357
1.52
2.26
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
422
1.47
2.26
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
42
262
1.61
2.25
2.6
1.6
u/field
1.8
3.4
0.80
30
201
(3002331) Protein [Mass/volume] in Peritoneal fluid
21
106
1.98
2.25
1.4
1.3
g/l
24.9
23.7
0.12
15
84
(3012494) Peanut IgE Ab [Units/volume] in Serum
29
164
1.77
2.22
1.1
1.1
u/ml
1.8
22.0
0.50
19
92
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
5
9
5.56
2.21
1.4
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
34
202
1.69
2.20
1.0
1.0
u/ml
9.4
10.6
—
5
42
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
13
54
2.41
2.19
1.2
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
159
1263
1.27
2.19
2.3
2.4
ug/min
139.5
135.9
0.03
111
800
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
17
80
2.13
2.18
1.4
1.6
%
19.0
8.0
—
6
40
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
8
24
3.34
2.18
9.6
4.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
171
2119
0.80
2.17
1.5
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
37
226
1.64
2.17
1.7
1.5
%
1.8
4.5
—
10
59
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
48
313
1.54
2.15
1.5
1.5
u/ml
30.2
25.8
—
10
69
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
30
3.00
2.14
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
51
338
1.51
2.13
2.0
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
46
298
1.55
2.13
1.8
1.5
nmol/l
1.3
1.1
0.37
32
233
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
17
81
2.10
2.12
1.2
1.1
—
7.5
—
0
10
(3032057) Clostridioides difficile [Presence] in Stool
18
88
2.05
2.11
2.1
1.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
37
2.71
2.10
6.2
4.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
224
1859
1.21
2.08
1.1
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
5
10
5.00
2.07
1.2
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
5
10
5.00
2.07
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2060
19568
1.08
2.07
2.2
2.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
15
4.00
2.04
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
244
2047
1.20
2.03
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
216
1792
1.21
2.02
2.6
2.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
25
140
1.79
2.00
8.6
6.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2191
20881
1.07
2.00
3.8
4.3
ug/l
2.5
2.9
0.36
2013
18987
(40758292) HTLV I+II Ab panel - Serum
19
97
1.96
1.99
1.7
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
33
202
1.64
1.94
12.2
13.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
84
1121
0.75
1.94
1.5
1.4
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
11
4.55
1.94
4.8
9.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
45
2.45
1.92
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
97
1266
0.76
1.92
1.4
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
92
1208
0.76
1.91
1.5
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
99
1.92
1.89
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
70
956
0.73
1.89
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
242
2044
1.19
1.89
1.5
1.6
mu/l
310.9
293.0
0.31
217
1869
(40760410) HLA-B [Type] by High resolution
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
7
22
3.18
1.88
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1555
14665
1.08
1.87
1.4
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
44
650
0.67
1.87
1.1
1.4
pmol/l
110.8
115.9
0.04
16
208
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
85
1124
0.75
1.86
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
85
1123
0.75
1.85
1.4
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
52
358
1.46
1.85
1.6
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
82
612
1.34
1.84
1.5
1.4
pmol/l
297.4
288.4
0.09
67
465
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
13
59
2.21
1.84
1.2
1.1
u/ml
0.0
0.0
—
7
35
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
85
1121
0.76
1.83
1.4
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
108
1.85
1.81
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
92
701
1.32
1.80
1.1
1.0
u/ml
0.5
0.6
0.07
36
153
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
156
1271
1.23
1.78
1.9
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
52
361
1.44
1.78
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
81
607
1.34
1.78
1.1
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
51
353
1.45
1.77
1.1
1.1
u/ml
3.3
1.8
0.40
24
89
(3020874) Milk IgE Ab [Units/volume] in Serum
50
345
1.45
1.77
1.1
1.1
u/ml
4.6
1.5
1.00
25
106
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
75
556
1.35
1.77
2.7
2.0
mg/l
20.0
22.5
0.24
21
147
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
115
907
1.27
1.74
1.1
1.1
iu/ml
61.8
624.3
0.51
22
225
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
52
363
1.44
1.74
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
33
209
1.58
1.73
1.2
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
16
82
1.95
1.69
1.3
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
609
5536
1.11
1.68
2.6
2.2
nmol/l
13.2
13.2
0.08
542
5002
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
55
2.18
1.67
1.1
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
28
173
1.62
1.63
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
69
918
0.75
1.62
1.5
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
34
221
1.54
1.61
3.1
2.0
umol/l
31.2
28.0
0.51
34
211
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
186
0.48
1.61
1.2
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
12
56
2.14
1.61
1.0
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
12
56
2.14
1.61
1.0
1.3
mg/l
13.1
10.4
0.26
12
51
(3043410) Blood group antigens tested for on Red Blood Cells
24
143
1.68
1.60
2.0
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48
336
1.43
1.60
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
59
429
1.38
1.59
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
220
1876
1.18
1.59
1.6
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
20
3.00
1.58
1.5
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
40
271
1.48
1.58
1.4
1.3
nmol/l
136.5
135.0
0.07
40
271
(3029075) Extractable nuclear Ab panel - Serum
24
144
1.67
1.57
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
70
922
0.76
1.54
1.5
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
78
1.93
1.54
1.1
1.2
%
36.7
58.6
—
6
36
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
33
2.43
1.53
4.1
3.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
14
71
1.97
1.53
1.1
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
42
0.00
1.52
0.0
1.2
—
2.4
—
0
8
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
21
2.86
1.50
1.2
1.0
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
86
1.86
1.50
1.9
1.5
ug/l
0.3
0.4
—
10
52
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
26
162
1.61
1.49
1.0
1.2
%
113.2
107.6
0.51
21
138
(3050129) First trimester maternal screen panel - Serum or Plasma
114
1406
0.81
1.48
1.4
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
14
72
1.95
1.48
1.1
1.0
—
—
—
0
0
(3025315) Body weight
9
37
2.43
1.47
6.2
2.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
77
592
1.30
1.47
2.4
2.2
pg
32.3
32.5
0.08
77
585
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
69
523
1.32
1.45
1.1
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
45
318
1.42
1.45
1.0
1.0
u/ml
0.9
2.6
—
10
41
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
28
2.50
1.45
1.0
1.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
6
22
2.73
1.43
3.7
7.7
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
22
2.73
1.43
5.7
3.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
30
196
1.53
1.42
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
91
719
1.27
1.42
1.5
1.4
u/l
20.6
21.9
0.15
71
598
(4027681)
50
363
1.38
1.40
1.3
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
27
173
1.56
1.39
1.0
1.2
g/l
0.3
0.3
0.73
20
141
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
58
432
1.35
1.39
1.1
1.1
mg/l
301.2
279.7
1.25
51
396
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
9
41
2.20
1.36
1.1
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
70
538
1.30
1.36
2.5
3.1
nmol/l
5.4
16.3
0.54
64
529
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
59
443
1.33
1.35
1.3
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
17
97
1.75
1.34
1.1
1.2
umol/24h
0.8
0.7
—
9
56
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
25
159
1.57
1.34
1.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
61
1.97
1.32
2.0
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
12
61
1.97
1.32
1.6
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
171
2002
0.85
1.31
1.6
1.7
mg/l
8.2
4.0
1.51
125
1389
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
218
1893
1.16
1.31
3.7
2.9
u/ml
50.4
53.6
0.11
209
1828
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
34
2.35
1.29
5.1
3.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
11
55
2.00
1.27
1.4
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1162
12263
0.94
1.27
2.5
2.7
ug/l
0.7
0.7
0.55
695
7367
(44806420)
21
130
1.62
1.26
1.9
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5301
52332
1.06
1.25
4.7
4.5
mmol/l
2.7
2.8
10.82
5000
48788
(40768441) Liver Pathology biopsy report
48
354
1.36
1.25
1.2
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
44
321
1.37
1.22
1.4
1.6
mmol/l
8.5
7.9
0.70
31
198
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
92
744
1.24
1.22
3.0
3.0
u/ml
4.3
525.5
0.81
87
704
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
18
108
1.67
1.22
1.5
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
10
49
2.04
1.22
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
118
981
1.21
1.20
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
461
4216
1.10
1.20
5.1
3.7
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
6
26
2.31
1.18
1.2
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
118
983
1.20
1.18
1.2
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
52
393
1.33
1.17
1.5
1.5
umol/l
72.2
71.5
—
5
34
(3013762) Body weight Measured
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
72
570
1.27
1.15
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
44
326
1.35
1.13
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
31
216
1.44
1.13
2.9
3.6
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
30
2.33
1.12
1.3
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
18
111
1.62
1.11
1.1
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
19
119
1.60
1.11
3.9
1.9
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
20
127
1.58
1.11
1.0
1.2
—
206.7
—
0
6
(3035933) Granulocytes/100 leukocytes in Blood
27
184
1.47
1.10
1.6
1.7
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
59
462
1.28
1.05
1.3
1.2
mg/l
43.2
41.5
0.11
52
379
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
29
203
1.43
1.05
1.1
1.1
ng/l
108.4
134.5
—
8
48
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
44
331
1.33
1.04
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
272
2441
1.12
1.04
1.2
1.1
titre
866.1
149.8
—
9
61
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5214
51530
1.05
1.03
4.3
4.1
mmol/l
4.5
4.6
14.84
4954
48352
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
46
1.96
1.03
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
55
430
1.28
1.00
1.3
1.3
mmol/l
12.5
11.6
0.35
24
117
(44806071)
12
68
1.77
1.00
1.2
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
51
395
1.29
1.00
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
9
48
1.88
1.00
1.2
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
48
1.88
1.00
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
59
466
1.27
1.00
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
139
1.51
0.99
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
21
139
1.51
0.99
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
41
308
1.33
0.99
1.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
9
49
1.84
0.98
2.2
1.5
—
158.7
—
0
6
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
29
206
1.41
0.98
1.1
1.1
u/l
52.2
24.1
0.84
20
156
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
29
206
1.41
0.98
1.1
1.1
u/l
121.2
90.8
0.43
22
163
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
23
2.17
0.98
1.0
1.1
nmol/l
273.8
226.2
—
5
23
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
148
1.49
0.97
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
57
450
1.27
0.97
1.2
1.1
mg/l
270.3
273.5
0.04
49
390
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
24
165
1.46
0.96
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5010
49496
1.05
0.96
3.9
3.7
mmol/l
1.4
1.3
10.74
4721
46002
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
13
77
1.69
0.95
2.0
1.7
ng/l
77.9
143.4
2.47
13
77
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
62
1.78
0.94
11.4
6.9
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
27
2.22
0.93
1.0
1.9
—
—
—
0
0
(1002224) Polysomnography panel
284
2576
1.11
0.92
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
22
150
1.47
0.92
1.3
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
9
52
1.73
0.92
1.1
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
55
1.82
0.92
1.3
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
17
110
1.55
0.90
3.6
2.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
102
1.57
0.90
1.1
1.1
—
—
—
0
0
(4211845)
32
236
1.36
0.89
2.8
3.6
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
6
29
2.07
0.89
1.0
1.0
u/ml
0.0
0.6
—
6
18
(3028679) Herpes simplex virus Ab [Presence] in Serum
37
280
1.32
0.88
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
81
675
1.20
0.87
1.7
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
32
238
1.35
0.85
2.9
2.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
194
1733
1.12
0.85
2.0
1.9
pmol/l
204.6
204.5
0.00
186
1650
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
17
112
1.52
0.84
8.1
7.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
45
1.78
0.84
1.6
2.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
18
121
1.49
0.82
1.1
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
73
608
1.20
0.81
1.4
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
147
1.43
0.80
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
58
1.73
0.79
4.5
2.1
u/field
0.7
0.6
—
10
58
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
48
1.67
0.78
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
91
776
1.18
0.78
1.1
1.1
u/ml
4.8
3.1
0.35
33
385
(3034274) Bile acid [Moles/volume] in Serum --fasting
70
583
1.20
0.78
2.2
2.2
umol/l
5.6
9.6
1.47
44
419
(3006270) Folate [Moles/volume] in Blood
55
448
1.23
0.76
1.2
1.2
nmol/l
338.3
369.1
0.54
43
393
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
191
1.36
0.76
1.2
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
86
732
1.18
0.76
1.6
1.5
nmol/l
0.3
0.4
0.39
66
604
(3002619) Bacteria identified in Specimen by Culture
15
99
1.52
0.75
1.7
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
53
1.70
0.75
4.1
3.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
39
306
1.28
0.74
5.3
7.4
u/ml
49.1
8389.7
—
8
83
(3039443) Prostate specific Ag panel - Serum or Plasma
144
1621
0.89
0.74
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
124
1091
1.14
0.72
1.3
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
56
1.61
0.72
1.1
1.2
umol/24h
2.1
1.6
—
9
56
(3001556) Androgen free Index in Serum or Plasma
9
57
1.58
0.71
1.1
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
26
1.92
0.70
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
20
275
0.73
0.70
1.5
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
270
2925
0.92
0.68
1.6
1.6
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.2
%
0.8
0.5
—
5
15
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
29
1.72
0.64
1.0
1.3
—
—
—
0
0
(4094501)
128
1431
0.89
0.62
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
651
6216
1.05
0.61
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
256
0.74
0.61
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
32
253
1.27
0.60
1.3
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
12
80
1.50
0.59
4.8
1.4
mmol/l
6.8
8.3
—
5
25
(3004775) Volume in Urine collected for unspecified duration
49
408
1.20
0.59
2.1
2.3
ml
657.6
661.8
0.03
36
280
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
287
2674
1.08
0.59
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
72
1.53
0.59
3.5
2.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
35
1.71
0.57
1.2
1.2
u/l
22.2
20.2
—
6
35
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
36
1.67
0.56
2.5
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
16
115
1.39
0.56
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
200
1843
1.09
0.55
1.5
1.4
u/l
8.5
7.9
0.26
161
1501
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
15
107
1.40
0.55
4.1
4.0
u/l
32.8
79.0
—
8
34
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.5
2.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
9
60
1.50
0.54
1.9
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
60
1.50
0.54
1.1
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
60
1.50
0.54
1.3
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
36
438
0.82
0.54
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
70
608
1.15
0.54
1.8
1.6
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
13
91
1.43
0.52
2.2
3.0
mg/l
13.6
24.1
—
6
21
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
588
5631
1.05
0.51
1.6
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
296
1.22
0.51
1.1
1.1
u/l
1.0
1.1
0.99
18
139
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
29
233
1.25
0.50
2.4
1.7
nmol/l
2.4
16.0
0.70
24
189
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
11
156
0.70
0.49
1.9
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
22
171
1.29
0.49
1.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
7
45
1.56
0.48
1.6
1.1
g/l
17.3
17.0
—
7
38
(3001729) Color of Synovial fluid
7
45
1.56
0.48
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5152
51162
1.03
0.48
4.3
4.1
mmol/l
1.3
1.4
23.15
4877
47789
(40768793) Breast Pathology biopsy report
70
795
0.88
0.48
1.3
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
52
448
1.16
0.46
3.5
5.1
u/ml
137.5
56.6
0.40
18
133
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
200
1.25
0.46
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
32
265
1.21
0.44
1.5
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
14
104
1.35
0.43
1.0
1.2
pmol/l
266.8
278.5
—
9
75
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
25
203
1.23
0.42
1.1
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
20
158
1.27
0.41
1.5
2.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
15.4
—
0
11
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
96
871
1.10
0.41
1.7
1.7
—
—
—
0
0
(3019225) pH of Specimen
430
4485
0.96
0.40
6.2
4.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
102
930
1.10
0.40
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
61
1.31
0.39
1.9
2.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
61
1.31
0.39
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
122
1123
1.09
0.39
5.7
3.3
mg/l
34.1
27.3
1.24
83
718
(3005011) Chlamydia sp Ab [Titer] in Serum
10
71
1.41
0.39
1.6
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
26
313
0.83
0.38
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
581
6015
0.96
0.38
10.7
6.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
9
67
1.34
0.38
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
67
1.34
0.38
1.1
1.0
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
9
68
1.32
0.37
1.2
1.9
pmol/l
15.9
42.1
—
9
57
(3017509) Phencyclidine [Presence] in Urine
9
68
1.32
0.37
2.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
23
279
0.82
0.37
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
108
993
1.09
0.36
1.7
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
65
582
1.12
0.36
1.5
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
247
2344
1.06
0.35
1.8
1.8
nmol/l
38.3
39.5
0.37
242
2285
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
432
1.14
0.35
1.2
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1710
16814
1.02
0.35
3.5
3.8
%
22.0
21.7
0.26
668
7301
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
15
118
1.27
0.33
1.1
1.1
u/ml
81.9
63.3
0.39
15
113
(4024509)
36
414
0.87
0.33
1.3
1.5
—
—
—
0
0
(4038314)
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
35
304
1.15
0.31
2.0
2.2
min
492.8
495.9
0.07
27
231
(3025130) Human papilloma virus identified in Specimen
46
517
0.89
0.31
1.6
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
570
1.11
0.31
1.4
1.3
nmol/l
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
121
1.24
0.28
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
85
1.29
0.28
1.4
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
32
280
1.14
0.27
2.2
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
612
6277
0.97
0.26
1.5
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
67
1.19
0.26
1.9
2.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
32
283
1.13
0.24
5.2
7.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
16
191
0.84
0.24
1.9
3.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
82
0.73
0.24
1.2
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
78
726
1.08
0.23
1.3
1.3
mmol/l
7.7
7.2
0.68
60
535
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
16
190
0.84
0.23
3.7
5.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
147
0.82
0.23
1.6
1.3
—
—
—
0
0
(4281824)
37
411
0.90
0.23
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
200
0.85
0.22
1.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
100
942
1.06
0.22
3.0
3.7
u/ml
257.6
796.8
1.00
91
870
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
11
0.00
0.21
0.0
1.0
—
841.1
—
0
11
(4133840)
21
182
1.15
0.21
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
246
2375
1.04
0.21
1.4
1.4
iu/l
23.7
23.4
0.06
203
2015
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
90
1.22
0.19
1.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
13
153
0.85
0.18
1.6
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
15
129
1.16
0.17
1.6
1.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
69
650
1.06
0.17
1.4
1.3
nmol/l
0.2
0.3
—
7
46
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
33
301
1.10
0.17
1.0
1.0
ng/l
35.7
43.3
0.58
20
208
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
33
301
1.10
0.17
1.0
1.0
ng/l
730.6
768.5
0.19
23
202
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
33
302
1.09
0.16
1.0
1.0
ng/l
203.0
314.9
3.83
24
211
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
9
79
1.14
0.15
3.8
5.6
ug/min
56.0
43.1
—
9
54
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
28
306
0.91
0.14
3.4
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
70
734
0.95
0.13
1.5
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
17
152
1.12
0.12
1.6
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
27
249
1.08
0.11
2.5
2.1
ug/min
135.8
217.5
—
9
66
(40765089) Chromosome analysis panel - Blood by G-banded
22
201
1.09
0.11
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
10
86
1.16
0.11
4.7
7.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
16
144
1.11
0.10
1.5
1.5
ug/l
8.0
8.4
0.21
16
144
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
13
116
1.12
0.09
3.9
2.9
—
—
—
0
0
(4146454)
51
488
1.05
0.09
2.6
2.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
58
1.03
0.08
1.3
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
85
1.06
0.07
2.4
2.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
87
1.03
0.07
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
90
0.89
0.06
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
130
1315
0.99
0.03
1.5
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
147
0.95
0.01
1.2
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
78
787
0.99
0.01
3.3
2.3
%
13.3
13.1
1.12
78
775
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
104
1.06
0.01
1.6
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
155
0.97
0.00
2.1
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
260
1.00
0.00
1.3
1.1
miu/ml
1421.4
1495.6
0.14
26
260
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
52
0.96
0.00
1.2
1.3
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
171.3
—
0
8
(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
30.0
—
0
7
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1586.7
—
0
6
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_ACUTELOWERNAS and mortality.

Females

Parameter HR [95% CI] p-value
J10_ACUTELOWERNAS 2.522 [2.2, 2.9] < 0.001
Birth year 0.992 [0.98, 1.0] 0.044

During the follow-up period (1.1.1998 — 31.12.2019), 5097 out of 15402 females with J10_ACUTELOWERNAS died.

Males

Parameter HR [95% CI] p-value
J10_ACUTELOWERNAS 2.888 [2.44, 3.42] < 0.001
Birth year 0.99 [0.98, 1.0] 0.022

During the follow-up period (1.1.1998 — 31.12.2019), 5409 out of 15571 males with J10_ACUTELOWERNAS died.

Mortality risk

Mortality risk for people of age

years, who have J10_ACUTELOWERNAS.

N-year risk Females Males
1 0.221% 0.55%
5 1.399% 3.759%
10 3.403% 8.868%
15 5.952% 16.599%
20 10.755% 27.09%

Relationships between endpoints

Index endpoint: J10_ACUTELOWERNAS – Unspecified acute lower respiratory infection

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data